+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 8018

Chapter 8018 contains a list of PDF Full Texts available from EurekaMag.

Rowley, M.; Leeson, P.; Grimwood, S.; Marshall, G.; Saywell, K., 1995:
5,6,7,8-tetrahydroquinolones as antagonists at the glycine site of the NMDA receptor

Siegmund, B.; Lietner, E.; Mayer, I.; Pfannhauser, W.; Farkas, P.; Sadecka, J.; Kovac, M., 1997:
5,6-Dihydro-2,4,6-trimethyl-4H-1,3,5-dithiazine-an aroma-active compound formed in course of the Likens-Nickerson extraction

Drewes, S.E.; Sehlapelo, B.M.; Horn, M.M.; Scott Shaw, R.; Sandor, P., 1995:
5,6-Dihydro-alpha-pyrones and two bicyclic tetrahydro-alpha-pyrone derivatives from Cryptocarya latifolia

Collett, L.A.; Davies Coleman, M.T.; Rivett, D.E.A., 1998:
5,6-Dihydro-alpha-pyrones from Syncolostemon argenteus

Davies Coleman, M.T.; Rivett, D.E.A., 1996:
5,6-Dihydro-alpha-pyrones from Syncolostemon parviflorus

Topp, H.; Duden, R.; Schoech, G., 1993:
5,6-Dihydrouridine: a marker ribonucleoside for determining whole body degradation rates of transfer RNA in man and rats

Sakairi, Y.; Jacobson, H.R.; Noland, T.D.; Capdevila, J.H.; Falck, J.R.; Breyer, M.D., 1995:
5,6-EET inhibits ion transport in collecting duct by stimulating endogenous prostaglandin synthesis

Matsui, K.; Kajiwara, T.; Hatanaka, A.; Waldmann, D.; Schreier, P., 1994:
5,6-Epoxidation of All-trans-retinoic Acid with Soybean Lipoxygenase-2 and -3

Stephenson, A.H.; Sprague, R.S.; Lonigro, A.J., 1998:
5,6-Epoxyeicosatrienoic acid reduces increases in pulmonary vascular resistance in the dog

Ishiguro, M.; Tanaka, R.; Namikawa, K.; Nasu, T.; Inoue, H.; Nakatsuka, T.; Oyama, Y.; Imajo, S., 1997:
5,6-Cis-penems: broad-spectrum anti-methicillin-resistant Staphylococcus aureus beta-lactam antibiotics

D'acquisto, F.; Carnuccio, R.; D'ischia, M.; Misuraca, G., 1995:
5,6-dihydroxyindole-2-carboxylic acid, a diffusible melanin precursor, is a potent stimulator of lipopolysaccharide-induced production of nitric oxide by J774 macrophages

Yamaguchi, M.; Hara, S.; Obata, K., 1995:
5,6-dimethoxy-2-(4'-hydrazinocarbonylphenyl)benzothiazole as a highly sensitive and stable fluorescence derivatization reagent for carboxylic acids in high performance liquid chromatography

Cassaday, H.J.; Mitchell, S.N.; Williams, J.H.; Gray, J.A., 1993:
5,7,-Dihydroxytryptamine lesions in the fornix-fimbria attenuate latent inhibition

Santucci, A.C.; Knott, P.J.; Haroutunian, V., 1995:
5,7-DHT-induced lesions of the nucleus basalis or frontal cortex do not block passive avoidance retention impairments produced by p-chloroamphetamine in rats

Bienkowski, P.; Iwinska, K.; Piasecki, J.; Kostowski, W., 1997:
5,7-Dihydroxytryptamine lesion does not affect ethanol-induced conditioned taste and place aversion in rats

Rohrbacher, J.; Krieglstein, K.; Honerkamp, S.; Lewen, A.; Misgeld, U., 1995:
5,7-dihydroxytryptamine uptake discriminates living serotonergic cells from dopaminergic cells in rat midbrain culture

Lowe, J.A.I.i; Qian, W.; Scott, P.J.; Mclean, S.; Bryce, D.K.; Crawford, R.T.; Bordner, J., 1994:
5,7-diphenyl-3-ureidohexahydroazepin-2-ones as cholecystokinin-B receptor ligands

Andreotti, D.; Rossi, T.; Marchioro, C., 1996:
5- and 7-Oxa trinems: Their synthesis and biological evaluation

Korshun, V.A.; Manasova, E.V.; Balakin, K.V.; Prokhorenko, I.A.; Buchatskii, A.G.; Berlin, Yu, A., 1996:
5-(1-pyrenylethynyl)-2'-deoxyuridine, a novel fluorescent nucleoside analogue

Kassis, A., I.; Adelstein, S.J.mes, 1996:
5-(125I)iodo-2'-deoxyuridine in the radiotherapy of solid CNS tumors in rats

Schell, P.; Engels, J., W., 1997:
5-(2,(2-methoxy)bornyl)tetrazole as catalyst for diastereoselective synthesis of 2'-deoxy dinucleoside (3',5')-methylphosphonates

Gagliardi, S.; Nadler, G.; Consolandi, E.; Parini, C.; Morvan, M.; Legave, M.N.; Belfiore, P.; Zocchetti, A.; Clarke, G.D.; James, I.; Nambi, P.; Gowen, M.; Farina, C., 1998:
5-(5,6-Dichloro-2-indolyl)-2-methoxy-2,4-pentadienamides: novel and selective inhibitors of the vacuolar H+-ATPase of osteoclasts with bone antiresorptive activity

Frejaville, C.; Karoui, H.; Tuccio, B.; Le-Moigne, F.; Culcasi, M.; Pietri, S.; Lauricella, R.; Tordo, P., 1995:
5-(Diethoxyphosphoryl)-5-methyl-1-pyrroline N-oxide: A new efficient phosphorylated nitrone for the in vitro and in vivo spin trapping of oxygen-centered radicals

Musachio, J., L.; Scheffel, U.; Finley, P., A.; Zhan, Y.; Mochizuki, T.; Wagner, H., N.,. Jr.;; Dannals, R., F., 1998:
5-(I-125/123)iodo-3(2(S)-azetidinylmethoxy)pyridine, a radioiodinated analog of A-85380 for in vivo studies of central nicotinic acetylcholine receptors

Grishina, O.; Volant, K.; Pansu, D.; Descroix-Vagne, M., 1998:
5-(N,N-dimethyl)-amiloride to discriminate the unidirectional electrolyte transports in rat small intestine and proximal colon in vivo

Wang, X.; Kleyman, T.R.; Tohda, H.; Marunaka, Y.; O'Brodovich, H., 1993:
5-(N-Ethyl-N-isopropyl)amiloride sensitive Na+ currents in intact fetal distal lung epithelial cells

Cai, S.X.; Huang, J.C.; Espitia, S.A.; Tran, M.; Ilyin, V.I.; Hawkinson, J.E.; Woodward, R.M.; Weber, E.; Keana, J.F., 1997:
5-(N-oxyaza)-7-substituted-1,4-dihydroquinoxaline-2,3-diones: novel, systemically active and broad spectrum antagonists for NMDA/glycine, AMPA, and kainate receptors

Castro, J.L.; Broughton, H.B.; Russell, M.G.; Rathbone, D.; Watt, A.P.; Ball, R.G.; Chapman, K.L.; Patel, S.; Smith, A.J.; Marshall, G.R.; Matassa, V.G., 1997:
5-(Piperidin-2-yl)- and 5-(homopiperidin-2-yl)-1,4-benzodiazepines: high-affinity, basic ligands for the cholecystokinin-B receptor

Stjernlof, P.; Elebring, T.; Andersson, B.; Svensson, A.; Svensson, K.; Ekman, A.; Carlsson, A.; Wikstrom, H., 1993:
5-, 6-, 7-, and 8-amino-2-(N,N-di-n-propylamino)-1,2,3,4-tetrahydronaphthalenes: Centrally acting DA and 5-HT-1A agonists

Chavis, C.; Chanez, P.; Vachier, I.; Bousquet, J.; Michel, F.B.; Godard, P., 1995:
5-15-diHETE and lipoxins generated by neutrophils from endogenous arachidonic acid as asthma biomarkers

Basch, C.E.; Zybert, P.; Shea, S., 1994:
5-A-DAY: dietary behavior and the fruit and vegetable intake of Latino children

Roediger, W., E.W.; Duncan, A., 1996:
5-ASA decreases colonic sulfide formation: Implications for ulcerative colitis

Andreoli, A.; Spinella, S.; Levenstein, S.; Prantera, C., 1994:
5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis

Fujita, M.; Egawa, H.; Miyamoto, T.; Nakano, J.; Matsumoto, J., 1996:
5-Alkoxyimidazoquinolones as potential antibacterial agents. Synthesis and structure-activity relationships

Canedo, L.M.; Miguel Del Corral, J.M.; San Feliciano, A., 1997:
5-Alkylresorcinols from Ononis natrix

Gong, Y.F.; Srinivas, R.V.; Fridland, A., 1993:
5-Amino-4-imidazolecarboxamide riboside potentiates the metabolism and anti-human immunodeficiency virus activity of 2',3'-dideoxyinosine

Corton, J., M.; Gillespie, J., G.; Hawley, S., A.; Hardie, D.G.ahame, 1995:
5-Aminoimidazole-4-carboxamide ribonucleoside: A specific method for activating AMP-activated protein kinase in intact cells?

Szabados, E.; Hindmarsh, E., J.; Philips, L.; Duggleby, R., G.; Christopherson, R., I., 1994:
5-Aminoimidazole-4-carboxamide ribotide transformylase-IMP cyclohydrolase from human CCRF-CEM leukemia cells: Purification, pH dependence, and inhibitors

Ferreira, G.C.; Gong, J., 1995:
5-Aminolevulinate Synthase and the First Step of Heme Biosynthesis

van der Werf, M.J.; Zeikus, J.G., 1996:
5-Aminolevulinate production by Escherichia coli containing the Rhodobacter sphaeroides hemA gene

Nagai, T.; Harigae, H.; Furuyama, K.; Munakata, H.; Hayashi, N.; Endo, K.; Sassa, S.; Yamamoto, M., 1997:
5-Aminolevulinate synthase expression and hemoglobin synthesis in a human myelogenous leukemia cell line

Bottomley, S., S.; Healy, H., M.; Brandenburg, M., A.; May, B., K., 1992:
5-Aminolevulinate synthase in sideroblastic anemias: mRNA and enzyme activity levels in bone marrow cells

Neidle, E.L.; Kaplan, S., 1993:
5-Aminolevulinic acid availability and control of spectral complex formation in hemA and hemT mutants of Rhodobacter sphaeroides

Gross, U.; Sassa, S.; Jacob, K.; Deybach, J.C.; Nordmann, Y.; Frank, M.; Doss, M.O., 1998:
5-Aminolevulinic acid dehydratase deficiency porphyria: a twenty-year clinical and biochemical follow-up

Moan, J.; Bech, O.; Peng, Q.; Berg, K., 1998:
5-Aminolevulinic acid in photochemotherapy and fluorescence diagnostics

Oteiza, P.I.; Kleinman, C.G.; Demasi, M.; Bechara, E.J., 1995:
5-Aminolevulinic acid induces iron release from ferritin

Onuki, J.; Medeiros, M.H.G.; Bechara, E.J.H.; D.M.scio, P., 1994:
5-Aminolevulinic acid induces single-strand breaks in plasmid pBR322 DNA in the presence of Fe-2+ ions

Fraga, C.G.; Onuki, J.; Lucesoli, F.; Bechara, E.J.; Di Mascio, P., 1994:
5-Aminolevulinic acid mediates the in vivo and in vitro formation of 8-hydroxy-2'-deoxyguanosine in DNA

Peng, Q.; Warloe, T.; Berg, K.; Moan, J.; Kongshaug, M.; Giercksky, K.-Erik; Nesland, J., M., 1997:
5-Aminolevulinic acid-based photodynamic therapy: Clinical research and future challenges

Sasikala, C.; Ramana, C.V.; Rao, P.R.ghuveer, 1994:
5-Aminolevulinic acid: A potential herbicide/insecticide from microorganisms

Acklin, P.; Allgeier, H.; Auberson, Y., P.; Bischoff, S.; Ofner, S.; Sauer, D.; Schmutz, M., 1998:
5-Aminomethylquinoxaline-2,3-diones, Part III: Arylamide derivatives as highly potent and selective glycine-site NMDA receptor antagonists

Auberson, Y., P.; Bischoff, S.; Moretti, R.; Schmutz, M.; Veenstra, S., J., 1998:
5-Aminomethylquinoxaline-2,3-diones. Part I: A novel class of AMPA receptor antagonists

Auberson, Y., P.; Acklin, P.; Allgeier, H.; Biollaz, M.; Bischoff, S.; Ofner, S.; Veenstra, S., J., 1998:
5-Aminomethylquinoxaline-2,3-diones. Part II: N-Aryl derivatives as novel NMDA/glycine and AMPA antagonists

Walker, A.M.; Szneke, P.; Bianchi, L.A.; Field, L.G.; Sutherland, L.R.; Dreyer, N.A., 1997:
5-Aminosalicylates, sulfasalazine, steroid use, and complications in patients with ulcerative colitis

Stevens, C.; Lipman, M.; Fabry, S.; Moscovitch-Lopatin, M.; Almawi, W.; Keresztes, S.; Peppercorn, M.A.; Strom, T.B., 1995:
5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells

Kane, J., M.; Staeger, M., A.; Dalton, C., R.; Miller, F., P.; Dudley, M., W.; Ogden, A.-Marie, L.; Kehne, J., H.; Ketteler, H., J.; Mccloskey, T., C.; Senyah, Y.; Chmielewski, P., A.; Miller, J., A., 1994:
5-Aryl-3-(alkylthio)-4H-1,2,4-triazoles as selective antagonists of strychnine-induced convulsions and potential antispastic agents

Denis, A.; Villette, T., 1994:
5-Aryl-beta,gamma butenolide, a new class of antibacterial derived from the N-aryl oxazolidinone DUP 721

Raman, R.; Narayan, G., 1995:
5-Aza deoxyCytidine-induced inhibition of differentiation of spermatogonia into spermatocytes in the mouse

Roth, B.J.; Elson, P.; Sledge, G.W.; Einhorn, L.H.; Trump, D.L., 1993:
5-Azacytidine (NSC 102816) in refractory germ cell tumors. A phase II trial of the Eastern Cooperative Oncology Group

Zagris, N.; Podimatas, T., 1994:
5-Azacytidine changes gene expression and causes developmental arrest of early chick embryo

Takai, T.; Yasuda, T.; Ohmori, H., 1995:
5-Azacytidine enhances transient expression of a transfected gene in cultured mammalian cells

Shao, W.; Hughes, K., W., 1995:
5-Azacytidine increases the activity of neomycin phosphotransferase II in transgenic Nicotiana tabacum: A posttranslational mechanism may play a role

Hossain, M.M.; Takashima, A.; Nakayama, H.; Doi, K., 1997:
5-Azacytidine induces toxicity in PC12 cells by apoptosis

Fernandez, J.L.; Goyanes, V.; Pereira, S.; Lopez Fernandez, C.; Gosalvez, J., 1994:
5-Azacytidine produces differential undercondensation of alpha, beta and classical human satellite DNAs

Sreekumar, G.P.; Erf, G.F.; Smyth, J.R.bert, J., 1996:
5-Azacytidine treatment induces autoimmune vitiligo in parental control strains of the Smyth line chicken model for autoimmune vitiligo

Taylor, E.; Mcfarlane, R.; Price, C., 1996:
5-Azacytidine treatment of the fission yeast leads to cytotoxicity and cell cycle arrest

Kim, E.Y.ung; Lee, S.G.l; Lee, S.W.o, 1992:
5-Azacytidine-induced derepression of genes on the inactive human X chromosome in Chinese hamster-human hybrid cell lines

Haaf, T.; Werner, P.; Schmid, M., 1993:
5-Azadeoxycytidine distinguishes between active and inactive X chromosome condensation

Naguib, F.N.M.; Levesque, D.L.; Wang, E.C.i; Panzica, R.P.; E.K.uni, M.H., 1993:
5-Benzylbarbituric acid derivatives, potent and specific inhibitors of uridine phosphorylase

Malendowicz, L.K.; Nussdorfer, G.G., 1996:
5-Bromo-2'-deoxyuridine stimulates the pituitary-adrenal axis in the rat: an effect blocked partially by endothelin-receptor antagonists

Young, R.W.; Sheedlo, H.J.; Li, L.; Turner, J.E., 1994:
5-Bromo-2-Deoxyuridine Labelling of Rabbit Retinal Pigment Epithelial Cells Grown on Polycarbonate Membrane Substrates

Thomas, L.; Chan, P.W.; Chang, S.; Damsky, C., 1993:
5-Bromo-2-deoxyuridine regulates invasiveness and expression of integrins and matrix-degrading proteinases in a differentiated hamster melanoma cell

Waldman, F.M.; Carroll, P.R.; Cohen, M.B.; Kerschmann, R.; Chew, K.; Mayall, B.H., 1993:
5-Bromodeoxyuridine incorporation and PCNA expression measures of cell proliferation in transitional cell carcinoma of the urinary bladder

Mukherjee, P., S.; Desilva, K., H.; Karnes, H.T.omas, 1995:
5-Bromomethyl fluorescein (5-BMF) for derivatization of carboxyl containing analytes for use with laser-induced fluorescence detection

Balasubramanian, G.; Lee, H.S.ng; Mah, S.C.in, 1995:
5-Carboxamidotryptamine attenuates the development of deoxycorticosterone acetate-salt hypertension in rats

Beer, M.S.; Stanton, J.A.; Hawkins, L.M.; Middlemiss, D.N., 1993:
5-Carboxamidotryptamine-insensitive 5-HT-1-like receptors are concentrated in guinea pig but not rat, claustrum

Hanthamrongwit, M.; Reid, W.H.; Courtney, J.M.; Grant, M.H., 1994:
5-Carboxyfluorescein diacetate as a probe for measuring the growth of keratinocytes

Daluge, S., M.; Purifoy, D., J.M.; Savina, P., M.; St-Clair, M., H.; Parry, N., R.; Dev, I., K.; Novak, P.; Ayers, K., M.; Reardon, J., E., 1994:
5-Chloro-2',3'-dideoxy-3'-fluorouridine (935U83), a selective anti-human immunodeficiency virus agent with an improved metabolic and toxicological profile

Greer, S.; Schwade, J.; Marion, H.S.an, 1995:
5-Chlorodeoxycytidine and biomodulators of its metabolism result in fifty to eighty percent cures of advanced EMT-6 tumor when used with fractionated radiation

Jaffe, E.K.; Petrovich, R.M.; Volin, M., 1995:
5-Chlorolevulinate interactions with Bradyrhizobium japonicum porphobilinogen synthase

Macor, J., E.; Blank, D., H.; Desai, K.; Fox, C., B.; Koe, B.K.nneth; Lebel, L., A.; Post, R., J.; Schmidt, A., W.; Schulz, D., W.; Seymour, P., A., 1995:
5-Cyano-1-(3-(N-methylpyrrolidin-2R-ylmethyl)indol-5-yl) benzimidazole (CP-161,242): A potent, centrally active 5-HT-1D receptor agonist and benzodiazepine partial agonist

Ram, V.-Ji; Goel, A.; Nath, M.; Srivastava, P., 1994:
5-Cyano-2-Thiouracils and Their Derivatives: A New Class of Leishmanicides

Catena, E.; Cesana, M.; Group, T.-Raecb-Study, 1995:
5-Day Rufloxacin Treatment Versus 7-Day Ciprofloxacin Treatment in Patients with Acute Exacerbations of Chronic Bronchitis: A Randomised Study

Soper, J.T.; Clarke-Pearson, D.L.; Berchuck, A.; Rodriguez, G.; Hammond, C.B., 1994:
5-day methotrexate for women with metastatic gestational trophoblastic disease

Urban, S.; Capon, R.J., 1992:
5-Epiisospongiaquinone, a new sesquiterpene/quinone antibiotic from an Australian marine sponge, Spongia hispida

Schwartz, E.L.; Baptiste, N.; Megati, S.; Wadler, S.; Otter, B.A., 1995:
5-Ethoxy-2'-deoxyuridine, a novel substrate for thymidine phosphorylase, potentiates the antitumor activity of 5-fluorouracil when used in combination with interferon, an inducer of thymidine phosphorylase expression

Porter, D., J.T.; Harrington, J., A.; Almond, M., R.; Lowen, G., T.; Zimmerman, T., P.; Spector, T., 1994:
5-Ethynyl-2(1H)-pyrimidinone: Aldehyde oxidase-activation to 5-ethynyluracil, a mechanism-based inactivator of dihydropyrimidine dehydrogenase

Cao, S.; Baccanari, D.P.; Joyner, S.S.; Davis, S.T.; Rustum, Y.M.; Spector, T., 1995:
5-Ethynyluracil (776C85): effects on the antitumor activity and pharmacokinetics of tegafur, a prodrug of 5-fluorouracil

Spector, T.; Harrington, J., A.; Porter, D., J.T., 1993:
5-Ethynyluracil (776C85): Inactivation of dihydropyrimidine dehydrogenase in vivo

Davis, S., T.; Joyner, S., S.; Baccanari, D., P.; Spector, T., 1994:
5-Ethynyluracil (776C85): Protection from 5-fluorouracil-induced neurotoxicity in dogs

Cao, S.; Rustum, Y.M.; Spector, T., 1994:
5-Ethynyluracil (776C85): modulation of 5-fluorouracil efficacy and therapeutic index in rats bearing advanced colorectal carcinoma

Ishida, F.; Omura, K.; Kanehira, E.; Hashimoto, T.; Watanabe, T.; Hirano, K.; Watanabe, S.; Watanabe, Y., 1994:
5-FU and CDDP for liver metastases originated from colorectal carcinoma

Nozue, M.; Todoroki, T.; Fukao, K., 1995:
5-FU dose dependency in MTX/5-FU sequential therapy assessed by in vitro assay using gastric cancer cell lines

Gokce, M.; Akata, R.F.kret; Kiremitci-Gumusderelioglu, M., 1996:
5-FU loaded pHEMA drainage implants for glaucoma-filtering surgery: Device design and in vitro release kinetics

Mahteme, H.; Larsson, B.S.; Sundin, A.; Graf, W., 1998:
5-FU uptake in liver metastases after intravenous and intraperitoneal administration: an autoradiographic study in the rat

Inada, T.; Ichikawa, A.; Kubota, T.; Ogata, Y.; Moossa, A.R.; Hoffman, R.M., 1997:
5-FU-induced apoptosis correlates with efficacy against human gastric and colon cancer xenografts in nude mice

Guo, X.; Lerner Tung, M.; Chen, H.X.ng; Chang, C.N.ng; Zhu, J.L.ang; Chang, C.P.ng; Pizzorno, G.; Lin, T.S.un; Cheng, Y.C.i, 1995:
5-Fluoro-2-pyrimidinone, a liver aldehyde oxidase-activated prodrug of 5-fluorouracil

Mcclinton, M., A.; Sik, V., 1992:
5-Fluorocyclopentadiene: Synthesis and utility

Consalvo, M.; Mullen, C.A.; Modesti, A.; Musiani, P.; Allione, A.; Cavallo, F.; Giovarelli, M.; Forni, G., 1995:
5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory

Summers, K.L.; Lippiello, P.; Verhulst, S.; Giacobini, E., 1995:
5-Fluoronicotine, noranhydroecgonine, and pyridylmethylpyrrolidine release acetylcholine and biogenic amines in rat cortex in vivo

Reed, E.; Jacob, J.; Ozols, R., F.; Young, R., C.; Allegra, C., 1992:
5-Fluorouracil (5-FU) and leucovorin in platinum-refractory advanced stage ovarian carcinoma

Rougier, P.; Paillot, B.; Laplanche, A.; Morvan, F.; Seitz, J.F.; Rekacewicz, C.; Laplaige, P.; Jacob, J.; Grandjouan, S.; Tigaud, J.M.; Fabri, M.C.; Luboinski, M.; Ducreux, M., 1997:
5-Fluorouracil (5-FU) continuous intravenous infusion compared with bolus administration. Final results of a randomised trial in metastatic colorectal cancer

Wu, X.P.; Dolnick, B.J., 1993:
5-Fluorouracil alters dihydrofolate reductase pre-mRNA splicing as determined by quantitative polymerase chain reaction

Chen, M.F.; Chen, L.T.; Boyce, H.W.rth, J., 1995:
5-Fluorouracil Cytotoxicity in Human Colon HT-2P Cells with Moderately Increased or Decreased Cellular Glutathione Level

Pfeiffer, N.; Grehn, F., 1993:
5-Fluorouracil after goniotrephination with scleral flap and fornix-based conjunctival flap

Porta, C.; Moroni, M.; Nastasi, G.; Arcangeli, G., 1995:
5-Fluorouracil and d,l-leucovorin calcium are active to treat unresectable hepatocellular carcinoma patients: preliminary results of a phase II study

Moser, R.; Hausmaninger, H.; Ludwig, H.; Fridrik, M.; Schmidt, H.; Mlineritsch, B.; Pecherstorfer, M.; Michlmayr, G.; Kopf, C.; Samonigg, H., 1995:
5-Fluorouracil and folinic acid with or without alpha-2c interferon in the treatment of metastatic colorectal cancer: Preliminary results of a multicenter prospective randomized phase-III trial

Tetef, M.; Doroshow, J.; Akman, S.; Coluzzi, P.; Leong, L.; Margolin, K.; Morgan, R., J.,. Jr.;; Raschko, J.; Shibata, S.; Somlo, G.; Ahn, C., 1995:
5-Fluorouracil and high-dose calcium leucovorin for hepatocellular carcinoma: A phase II trial

Logothetis, C.J.; Hossan, E.; Recondo, G.; Sella, A.; Ellerhorst, J.; Kilbourn, R.; Zukiwski, A.; Amato, R., 1994:
5-Fluorouracil and interferon-alpha in chemotherapy refractory bladder carcinoma: an effective regimen

John, W., J.; Neefe, J., R.; Macdonald, J., S.; Cantrell, J.,. Jr.;; Smith, M., 1993:
5-Fluorouracil and interferon-alpha-2a in advanced colorectal cancer: Results of two treatment schedules

Lucchinetti, C.F.; Kimmel, D.W.; Pavelko, K.; Rodriguez, M., 1997:
5-Fluorouracil and levamisole exacerbate demyelination in susceptible mice infected with Theiler's virus

Fried, G.; Tsalik, M.; Stein, M.; Dale, J.; Haim, N., 1995:
5-Fluorouracil and low-dose leucovorin in metastatic colorectal cancer: a pilot study

Shinohara, N.; Demura, T.; Matsumura, K.; Toyoda, K.; Kashiwagi, A.; Nagamori, S.; Ohmuro, H.; Ohzono, S.; Koyanagi, T., 1998 :
5-fluorouracil and low-dose recombinant interferon-alpha-2a in patients with hormone-refractory adenocarcinoma of the prostate

Furuya, Y.; Yamamoto, K.; Kohno, N.; Ku, Y.; Saitoh, Y., 1994:
5-Fluorouracil attenuates an oncostatic effect of melatonin on estrogen-sensitive human breast cancer cells (MCF7)

Bourgeois, H.; Perault, M.C.; Raud-Raynier, P.; Favreliere, S.; Daban, A.; Vandel, B., 1993:
5-Fluorouracil cardiotoxicity: Clinical tables about four cases and preventive proposition

Porta, C.; Moroni, M.; Nastasi, G., 1995:
5-Fluorouracil combined with the pure l-stereoisomer of leucovorin calcium to treat advanced colon cancer patients: A phase-II study

Tan, E.H.; Ang, P.T., 1996:
5-Fluorouracil continuous infusion in metastatic colorectal cancer

Campos, J.; Pineda, M.J.; Gomez, J.A.; Entrena, A.; Trujillo, M.A.; Gallo, M.A.; Espinosa, A., 1996:
5-Fluorouracil derivatives: I. Acyclonucleosides through a tin (IV) chloride-mediated regiospecific ring opening of alkoxy-1,4-diheteropanes

Ozaki, S.; Kong, X.; Watanabe, Y.; Hoshiko, T.; Koga, T.; Ogasawara, T.; Takizawa, T.; Fujisawa, H.; Iigo, M.; Hoshi, A., 1997:
5-Fluorouracil derivatives. XXII. Synthesis and antitumor activities of 1-carbamoyl-5-fluorouracils

Tsai, J.C.; Feuer, W.J.; Parrish, R.K.; Grajewski, A.L., 1995:
5-Fluorouracil filtering surgery and neovascular glaucoma. Long-term follow-up of the original pilot study

Goldenfeld, M.; Krupin, T.; Ruderman, J.M.; Wong, P.C.; Rosenberg, L.F.; Ritch, R.; Liebmann, J.M.; Gieser, D.K., 1994:
5-Fluorouracil in initial trabeculectomy. A prospective, randomized, multicenter study

Kamm, Y.J.; Wagener, D.J.; Rietjens, I.M.; Punt, C.J., 1998:
5-Fluorouracil in colorectal cancer: rationale and clinical results of frequently used schedules

Gandolfi, S.A.; Vecchi, M., 1997:
5-fluorouracil in combined trabeculectomy and clear-cornea phacoemulsification with posterior chamber intraocular lens implantation. A one-year randomized, controlled clinical trial

Okamoto, S.; Sakai, M.; Uchida, J.; Saito, H., 1996:
5-Fluorouracil induces apoptotic cell death with G2 phase arrest in human breast cancer grafted in nude mice

Vulimiri, S.V.; Nayak, R., 1994:
5-Fluorouracil induces structural changes in rat liver tRNA

Reinhard, T.; Klueppel, M.; Sundmacher, R., 1993:
5-Fluorouracil injection after filtering surgery

Welch, M., L.; Grabski, W., J.; Mccollough, M., L.; Skelton, H., G.; Smith, K., J.; Menon, P., A.; Anderson, L., L., 1997:
5-Fluorouracil iontophoretic therapy for Bowen's disease

Kamm, Y.J.L.; Heerschap, A.; Rietjens, G.V.R.senbuschonne M.C.M.; Vervoort, J.; Wagener, D.J.T.eo, 1996:
5-Fluorouracil metabolite patterns in viable and necrotic tumor areas of murine colon carcinoma determined by 19F NMR spectroscopy

Vulimiri, S.V.; Nayak, R., 1993:
5-Fluorouracil modulates aminoacylation of rat liver tRNA

White, R.M., 1995:
5-fluorouracil modulates the toxicity of high dose methotrexate

Steinke, B.; Guenther, E.; Hirschmann, W.; Sondern, W.; Koniczeck, K.H.; Wander, H.E.; Natt, F.; Wagner, T.; Hinrichs, H.F.; Roth, W., 1993:
5-Fluorouracil monotherapy versus folinic acid and 5-fluorouracil in advanced colorectal cancer: Results of a randomized trial

Rice, A.; Barbot, C.; Lacombe, F.; Dubosc-Marchenay, N.; Marit, G.; Hau, F.; Boiron, J.M.; Reiffers, J., 1993:
5-fluorouracil permits access to a primitive subpopulation of peripheral blood stem cells

Stein, T.A.; Burns, G.P.; Bailey, B.; Citron, M.L., 1994:
5-Fluorouracil pharmacokinetics in patients with metastatic colorectal carcinoma after high-dose leucovorin

Bolli, E.; Saccomanno, S.; Mondini, G.; Aschele, C.; Guglielmi, A.; Ligas, B.; Connio, M.; Mori, A.; Rosso, R.; Sobrero, A.; Tixi, L.; Pugliese, V., 1995:
5-Fluorouracil plus 5-methyltetrahydrofolate in advanced pancreatic cancer

Palmeri, S.; Meli, M.; Danova, M.; Bernardo, G.; Leonardi, V.; Dastoli, G.; Rausa, L.; Russo, A.; Filippelli, G.; Palmieri, G.; Russo, A.; Della Vittoria Scarpati, M.; Lo Russo, V.; Di Lauro, L.; Colucci, G.; Bruni, G.; Piazzi, M.; Gebbia, N.; Spada, S., 1998:
5-Fluorouracil plus interferon alpha-2a compared to 5-fluorouracil alone in the treatment of advanced colon carcinoma: a multicentric randomized study

Negishi, Koroku, 1994:
5-Fluorouracil reduces proliferating cell nuclear antigen immunoreactive cells in goldfish retina

Sasson, Z.; Morgan, C.D.; Wang, B.; Thomas, G.; MacKenzie, B.; Platts, M.E., 1994:
5-Fluorouracil related toxic myocarditis: case reports and pathological confirmation

Blanco, M.D.lores; Garcia, O.; Trigo, R., M.; Teijon, J., M.; Katime, I., 1996:
5-Fluorouracil release from copolymeric hydrogels of itaconic acid monoester: I. Acrylamide-co-monomethyl itaconate

Jin, Y.; Heck, D.E.; DeGeorge, G.; Tian, Y.; Laskin, J.D., 1996:
5-Fluorouracil suppresses nitric oxide biosynthesis in colon carcinoma cells

Loehrer, P., J.-Sr; Harry, D.; Chlebowski, R., T., 1994:
5-Fluorouracil vs. epirubicin vs. 5-fluorouracil plus epirubicin in advanced gastric carcinoma

Farhat, F.; Kattan, J.; Culine, S.; Bekradda, M.; Droz, J.P., 1994:
5-Fluorouracil, Adriamycin and cisplatinum (FAP regimen) efficacy in metastatic adenoid cystic carcinoma: A case report and review of the literature

Bajetta, E.; Rimassa, L.; Carnaghi, C.; Seregni, E.; Ferrari, L.; D.B.rtolomeo, M.; Regalia, E.; Cassato, A.; Procopio, G.; Mariani, L., 1998:
5-Fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors

Carmo-Pereira, J.; Henriques, E.; Costa, F.O.iveira, 1995:
5-Fluorouracil, epirubicin and cyclophosphamide, as first-line cytotoxic chemotherapy for disseminated breast carcinoma. A phase II study

Tsavaris, N.B.; Tentas, K.; Kosmidis, P.; Mylonakis, N.; Sakelaropoulos, N.; Kosmas, C.; Lisaios, B.; Soumilas, A.; Mandrekois, D.; Tsetis, A.; Klonaris, C., 1996:
5-Fluorouracil, epirubicin, and mitomycin C versus 5-fluorouracil, epirubicin, mitomycin C, and leucovorin in advanced gastric carcinoma. A randomized trial

Tsavaris, N.; Tentas, K.; Bacoyiannis, C.; Katsikas, M.; Sakelaropoulos, N.; Kosmas, C.; Daliani, D.; Kosmidis, P., 1995:
5-Fluorouracil, folinic acid and cisplatin in advanced colorectal cancer: a pilot study

Stahl, M.; Wilke, H.; Meyer, H.J.achim; Preusser, P.; Berns, T.; Fink, U.; Achterrath, W.; Knipp, H.; Harstrick, A.; Berger, M.; Schmoll, H.J.achim, 1994:
5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagus

Seitz, J.F.; Perrier, H.; Giovannini, M.; Capodano, G.; Bernardini, D.; Bardou, V.J., 1998:
5-Fluorouracil, high-dose folinic acid and mitomycin C combination chemotherapy in previously treated patients with advanced colorectal carcinoma

Akhtar, S.S.; Wani, B.A.; Bano, Z.A.; Salim, K.P.; Handoo, F.A., 1996:
5-Fluorouracil-induced severe but reversible cardiogenic shock: a case report

Akbuğa, J.; Bergişadi, N., 1996:
5-Fluorouracil-loaded chitosan microspheres: preparation and release characteristics

Parr, A.L.; Drake, J.C.; Gress, R.E.; Schwartz, G.; Steinberg, S.M.; Allegra, C.J., 1998:
5-Fluorouracil-mediated thymidylate synthase induction in malignant and nonmalignant human cells

Buchholz, D.J.; Lepek, K.J.; Rich, T.A.; Murray, D., 1995:
5-Fluorouracil-radiation interactions in human colon adenocarcinoma cells

Jazwiec, B.; Mahon, F.X.; Pigneux, A.; Pigeonnier, V.; Reiffers, J., 1995:
5-Fluorouracil-resistant CD34+ cell population from peripheral blood of CML patients contains BCR-ABL-negative progenitor cells

Cordel, S.; Heymann, M.F.ancoise; Boisteau, O.; Oliver, L.; L.P.ndu, J.; Gregoire, M.; Meflah, K., 1997:
5-Fluorouracil-resistant colonic tumors are highly responsive to sodium butyrate/interleukin-2 bitherapy in rats

Van Der Wilt, C.L.; Van Groeningen, C.J.; Pinedo, H.M.; Smid, K.; Hoekman, K.; Meijer, S.; Peters, G.J., 1997:
5-Fluorouracil/leucovorin-induced inhibition of thymidylate synthase in normal tissues of mouse and man

Buter, J.; Sinnige, H.A.M.; Sleijfer, D.T.; D.V.ies, E.G.E.; Willemse, P.H.B.; Van Der Graaf, W.T.A.; Verschueren, R.C.J.; Mulder, N.H., 1995:
5-Fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer

Fresta, M.; Villari, A.; Puglisi, G.; Cavallaro, G., 1993:
5-Fluorouracil: Various kinds of loaded liposomes: Encapsulation efficiency, storage stability and fusogenic properties

Girgis, S.; Suh, J.R.n; Jolivet, J.; Stover, P.J., 1997:
5-Formyltetrahydrofolate regulates homocysteine remethylation in human neuroblastoma

Kruschwitz, H.L.; McDonald, D.; Cossins, E.A.; Schirch, V., 1994:
5-Formyltetrahydropteroylpolyglutamates are the major folate derivatives in Neurospora crassa conidiospores

Foley, T.D., 1997:
5-HPETE is a potent inhibitor of neuronal Na+, K(+)-ATPase activity

Kumasegawa, T.; Arakawa, O., 1995:
5-HT Receptor agonist effect on single and paired rat open-field behavior

Kuwahara, A.; Kuramoto, H.; Kadowaki, M., 1998:
5-HT activates nitric oxide-generating neurons to stimulate chloride secretion in guinea pig distal colon

Henning, J.; Becker, H.; Netter, P., 1995:
5-HT agonist-induced changes in peripheral immune cells in healthy volunteers: The impact of personality

Perrone, R.; Berardi, F.; Leopoldo, M.; Tortorella, V.; Lograno, M.D.; Daniele, E.; Govoni, S., 1994:
5-HT and DA receptor affinity of arylpiperazine derivatives with terminal benzamide fragment

Lawton, C.L.; Blundell, J.E., 1993:
5-HT and carbohydrate suppression: effects of 5-HT antagonists on the action of d-fenfluramine and DOI

Mannel, M.; Mueller-Oerlinghausen, B.; Czernik, A.; Sauer, H., 1997:
5-HT brain function in affective disorder: d,l-fenfluramine-induced hormone release and clinical outcome in long-term lithium/carbamazepine prophylaxis

Pei, Q.; Leslie, R.A.; Grahame-Smith, D.G.; Zetterström, T.S., 1995:
5-HT efflux from rat hippocampus in vivo produced by 4-aminopyridine is increased by chronic lithium administration

Chi, J.; Kemerer, J.; Stephens, R.L., 1996:
5-HT in DVC: disparate effects on TRH analogue-stimulated gastric acid secretion, motility, and cytoprotection

Albuquerque, F.C.; Smith, E.H.; Kellum, J.M., 1998:
5-HT induces cAMP production in crypt colonocytes at a 5-HT4 receptor

E.M.nira, A.; Zhang, W.; Svensson, E.; Bussières, N., 1997:
5-HT inhibits calcium current and synaptic transmission from sensory neurons in lamprey

Di Prisco, G.V.; Dubuc, R.; Grillner, S., 1994:
5-HT innervation of reticulospinal neurons and other brainstem structures in lamprey

Colado, M.I.; Murray, T.K.; Green, A.R., 1993:
5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine

Lawton, C.L.; Blundell, J.E., 1993:
5-HT manipulation and dietary choice: Variable carbohydrate (Polycose) suppression demonstrated only under specific experimental conditions

Pype, J.L.; Verleden, G.M.; Demedts, M.G., 1994:
5-HT modulates noncholinergic contraction in guinea pig airways in vitro by prejunctional 5-HT1-like receptor

Kehne, J., H.; Padich, R., A.; Mccloskey, T., C.; Taylor, V., L.; Schmidt, C., J., 1996:
5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wister rats

Padich, R., A.; Mccloskey, T., C.; Kehne, J., H., 1996:
5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT-2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats

Hoyer, D.; Martin, G., 1997:
5-HT receptor classification and nomenclature: Towards a harmonization with the human genome

Mengod, G.; Vilaró, M.T.; Raurich, A.; López-Giménez, J.F.; Cortés, R.; Palacios, J.M., 1996:
5-HT receptors in mammalian brain: receptor autoradiography and in situ hybridization studies of new ligands and newly identified receptors

Bax, W.A.; Renzenbrink, G.J.; Van Heuven Nolsen, D.; Thijssen, E.J.M.; Bos, E.; Saxena, P.R., 1993:
5-HT receptors mediating contractions of the isolated human coronary artery

Walcourt-Ambakederemo, A.; Winlow, W., 1994:
5-HT receptors on identified Lymnaea neurones in culture: pharmacological characterization of 5-HT2 receptors

Walcourt-Ambakederemo, A.; Winlow, W., 1995:
5-HT receptors on identified Lymnaea neurones in culture: pharmacological characterization of 5-HT3 receptors

Grider, J.R.; Kuemmerle, J.F.; Jin, J.G., 1996:
5-HT released by mucosal stimuli initiates peristalsis by activating 5-HT4/5-HT1p receptors on sensory CGRP neurons

Behan, P.O.; Hannifah, H., 1995:
5-HT reuptake inhibitors in CFS

Goodchild, C.S.; Guo, Z.; Freeman, J.; Gent, J.P., 1997:
5-HT spinal antinociception involves mu opioid receptors: cross tolerance and antagonist studies

McCreary, A.C.; McBlane, J.W.; Spooner, H.A.; Handley, S.L., 1996:
5-HT systems and anxiety: multiple mechanisms in the elevated X-maze

Hrdina, P., D.; Demeter, E.; Vu, T., B.; Sotonyi, P.; Palkovits, M., 1993:
5-HT uptake sites and 5-HT-2 receptors in brain of antidepressant-free suicide victims/depressives: Increase in 5-HT-2 sites in cortex and amygdala

Adell, A.; Myers, R.D., 1995:
5-HT, dopamine, norepinephrine, and related metabolites in brain of low alcohol drinking (LAD) rats shift after chronic intra-hippocampal infusion of harman

Yildiz, O.; Tuncer, T., 1995:
5-HT-1-like and 5-HT-2A receptors mediate 5-hydroxytryptamine-induced contraction of rabbit isolated mesenteric artery

Yildiz, O.; Ciçek, S.; Ay, I.; Tatar, H.; Tuncer, M., 1996:
5-HT1-like receptor-mediated contraction in the human internal mammary artery

Maclean, M.R.; Clayton, R.A.; Hillis, S.W.; Mcintyre, P.D.; Peacock, A.J.; Templeton, A.G.B., 1994:
5-HT-1-receptor-mediated vasoconstriction in bovine isolated pulmonary arteries: Influences of vascular endothelium and tone

Wilkinson, L.O.; Middlemiss, D.N.; Hutson, P.H., 1994:
5-HT1A receptor activation increases hippocampal acetylcholine efflux and motor activity in the guinea pig: agonist efficacy influences functional activity in vivo

Azmitia, E.C.; Rubinstein, V.J.; Strafaci, J.A.; Rios, J.C.; Whitaker Azmitia, P.M., 1995:
5-HT-1A agonist and dexamethasone reversal of para-chloroamphetamine induced loss of MAP-2 and synaptophysin immunoreactivity in adult rat brain

Galeotti, N.; Ghelardini, C.; Bartolini, A., 1997:
5-HT-1A agonist induce central cholinergic antinociception

Quartermain, D.; Clemente, J.; Shemer, A., 1993:
5-HT-1A agonists disrupt memory of fear conditioning in mice

Marrosu, F.; Fornal, C., A.; Metzler, C., W.; Jacobs, B., L., 1996:
5-HT-1A agonists induced hippocampal theta activity in freely moving cats: Role of presynaptic 5-HT-1A receptors

Griebel, G.; Blanchard, D.C.roline; Jung, A.; Masuda, C.K.; Blanchard, R.J., 1995:
5-HT-1A agonists modulate mouse antipredator defensive behavior differently from the 5-HT-2A antagonist pirenperone

Pomerantz, S.M.; Hepner, B.C.; Wertz, J.M., 1993:
5-HT1A and 5-HT1C/1D receptor agonists produce reciprocal effects on male sexual behavior of rhesus monkeys

Abdel Fattah, A.F.ttah Mohamed; Matsumoto, K.; E.H.dy, K.A.del Wahed; Watanabe, H., 1995:
5-HT-1A and 5-HT-2 receptors mediate hypo- and hyperthermic effects of tryptophan in pargyline-pretreated rats

Burnet, P.W.; Eastwood, S.L.; Harrison, P.J., 1996:
5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia

Roychowdhury, S.; Haas, H.; Anderson, E.G., 1994:
5-HT-1A and 5-HT-4 receptor colocalization on hippocampal pyramidal cells

Pan, H.; Galligan, J.J., 1994:
5-HT1A and 5-HT4 receptors mediate inhibition and facilitation of fast synaptic transmission in enteric neurons

Perrone, R.; Berardi, F.; Leopoldo, M.; Tortorella, V.; Lograno, M.D.; Daniele, E.; Govoni, S., 1995:
5-HT1A and D-2 receptor affinity of o-methoxyphenylpiperazine derivatives with terminal benzamide fragment on N-4 alkyl chain. 2

Gonzalez, L.E.; Andrews, N.; File, S.E., 1996:
5-HT-1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze

Riekkinen, Paavo Jr, 1994:
5-HT-1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior

Hjorth, S.; Pettersson, G., 1993:
5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo

Garnovskaya, M.N.; Gettys, T.W.; van Biesen, T.; Prpic, V.; Chuprun, J.K.; Raymond, J.R., 1997:
5-HT1A receptor activates Na+/H+ exchange in CHO-K1 cells through Gialpha2 and Gialpha3

Kumasegawa, T.; Arakawa, O., 1994:
5-HT-1A receptor agonist effect on single and paired rat open-field behavior

Compaan, J.C.; Groenink, L.; Van Der Gugten, J.; Maes, R.A.A.; Olivier, B., 1996:
5-HT-1A receptor agonist flesinoxan enhances Fos immunoreactivity in rat central amygdala, bed nucleus of the stria terminalis and hypothalamus

Assie, M.-Bernadette; Cosi, C.; Koek, W., 1997:
5-HT-1A receptor agonist properties of the antipsychotic, nemonapride: Comparison with bromerguride and clozapine

Huang, J.; Strafaci, J.A.; Azmitia, E.C., 1997:
5-HT-1A receptor agonist reverses adrenalectomy-induced loss of granule neuronal morphology in the rat dentate gyrus

Cole, B.J.; Jones, G.H.; Turner, J.D., 1994:
5-HT-1A receptor agonists improve the performance of normal and scopolamine-impaired rats in an operant delayed matching to position task

Mendelson, S.D.; Quartermain, D.; Francisco, T.; Shemer, A., 1993:
5-HT-1A receptor agonists induce anterograde amnesia in mice through a postsynaptic mechanism

De-Vry, J., 1995:
5-HT-1A receptor agonists: Recent developments and controversial issues

Uphouse, L.; Andrade, M.; Caldarola Pastuszka, M.; Jackson, A., 1996:
5-HT-1A receptor antagonists and lordosis behavior

Arborelius, L.; Nomikos, G.G.; Grillner, P.; Hertel, P.; Hook, B.B.cklund; Hacksell, U.; Svensson, T.H., 1995:
5-HT-1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram

Lowther, S.; D.P.ermentier, F.; Cheetham, S.C.; Crompton, M.R.fus; Katona, C.L.E.; Horton, R.W., 1997:
5-HT-1A receptor binding sites in post-mortem brain samples from depressed suicides and controls

Simon, P.; Bertrand, J.; Costentin, J., 1993:
5-HT1A receptor blockade increases penile erections induced by indirect serotonin agonists

Nishi, M.; Azmitia, E.C., 1996:
5-HT-1A receptor expression is modulated by corticosteroid receptor agonists in primary rat hippocampal culture

Cervo, L.; Samanin, R., 1995:
5-HT-1A receptor full and partial agonists and 5-HT-2C (but not 5-HT-3) receptor antagonists increase rates of punished responding in rats

Kheck, N.M.; Gannon, P.J.; Azmitia, E.C., 1995:
5-HT1A receptor localization on the axon hillock of cervical spinal motoneurons in primates

Cowen, P.J.; Power, A.C.; Ware, C.J.; Anderson, I.M., 1994:
5-HT1A receptor sensitivity in major depression. A neuroendocrine study with buspirone

Odagaki, Yuji; Fuxe, Kjell, 1995:
5-HT-1A receptor-mediated activation of high-affinity GTPase in rat hippocampal membranes

Manahan-Vaughan, D.; Anwyl, R.; Rowan, M.J., 1994:
5-HT1A receptor-mediated inhibition in the hippocampus of the alert rat--effects of repeated gepirone treatment

Koike, H.; Saito, H.; Matsuki, N., 1994:
5-HT1A receptor-mediated inhibition of N-type calcium current in acutely isolated ventromedial hypothalamic neuronal cells

Dietrich, C.; Kilbinger, H., 1996:
5-HT-1A receptor-mediated inhibition of acetylcholine release from guinea pig myenteric plexus: Potential mechanisms

Kishimoto, T.; Yamanaka, T.; Amano, T.; Todo, N.; Sasa, M., 1994:
5-HT-1A receptor-mediated inhibition of lateral vestibular nucleus neurons projecting to the abducens nucleus

Lalley, P.M.; Bischoff, A.M.; Richter, D.W., 1994:
5-HT-1A receptor-mediated modulation of medullary expiratory neurones in the cat

Bervoets, K.; Rivet, J.M.; Millan, M.J., 1993:
5-HT-1A receptors and the tail-flick response: IV. Spinally localized 5-HT-1A receptors postsynaptic to serotoninergic neurons mediate spontaneous tail-flicks in the rat

Bartoszyk, G.D.; Roos, C.; Ziegler, H., 1996:
5-HT1A receptors are not involved in clozapine's lack of cataleptogenic potential

Wegener, G.; Smith, D.F.; Rosenberg, R., 1997:
5-HT-1A receptors in lithium-induced conditioned taste aversion

Andrews, N.; Hogg, S.; Gonzalez, L.E.; File, S.E., 1994:
5-HT1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively

Zemlan, F.P.; Murphy, A.Z.; Behbehani, M.M., 1994:
5-HT1A receptors mediate the effect of the bulbospinal serotonin system on spinal dorsal horn nociceptive neurons

Sánchez, C.., 1996:
5-HT(1A) receptors play an important role in modulation of behavior of rats in a two-compartment black and white box

Odagaki, Yuji; Fuxe, Kjell, 1995:
5-HT-1A, GABA-B, and pirenzepine-insensitive muscarinic receptors are functionally coupled to distinct pools of the same kind of G proteins in rat hippocampus

Ichimaru, Y.; Egawa, T.; Sawa, A., 1995:
5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice

Moore, N., A.; Rees, G.; Sanger, G.; Perrett, L., 1993:
5-HT-1A-mediated lower lip retraction: Effects of 5-HT-1A agonists and antagonists

Kuipers, W.; Kruse, C.G.; van Wijngaarden, I.; Standaar, P.J.; Tulp, M.T.; Veldman, N.; Spek, A.L.; IJzerman, A.P., 1997:
5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines

Craig, D.A.; Martin, G.R., 1993:
5-HT-1B receptors mediate potent contractile responses to 5-HT in rat caudal artery

Pauwels, Petrus, J., 1997:
5-HT-1B/D receptor antagonists

Kennett, G.A., 1992:
5-HT-1C receptor antagonists have anxiolytic-like actions in the rat social interaction model

Kuoppamaki, M.; Palvimaki, E.P.kka; Syvalahti, E.; Hietala, J., 1994:
5-HT1C receptor-mediated phosphoinositide hydrolysis in the rat choroid plexus after chronic treatment with clozapine

Chaouloff, F.; Layeillon, C.; Baudrie, V., 1993:
5-HT-1C/5-HT-2 receptor blockade prevents 1-(2,5-dimethoxy-4-iodophenyl)2-aminopropane-, but not stress-induced increases in brain tryptophan

Piñeyro, G.; de Montigny, C.; Blier, P., 1995:
5-HT1D receptors regulate 5-HT release in the rat raphe nuclei. In vivo voltammetry and in vitro superfusion studies

Starkey, S.J.; Skingle, M., 1994:
5-HT-1D as well as 5-HT-1A autoreceptors modulate 5-HT release in the guinea-pig dorsal Raphe nucleus

Longmore, J.; Boulanger, C.M.; Desta, B.; Hill, R.G.; Schofield, W.N.; Taylor, A.A., 1996:
5-HT-1D receptor agonists and human coronary artery reactivity in vitro: Crossover comparisons of 5-HT and sumatriptan with rizatriptan and L-741,519

Cattaneo, M.G.; Palazzi, E.; Bondiolotti, G.; Vicentini, L.M., 1994:
5-HT-1D receptor type is involved in stimulation of cell proliferation by serotonin in human small cell lung carcinoma

Johnson, K.W.; Schaus, J.M.; Durkin, M.M.; Audia, J.E.; Kaldor, S.W.; Flaugh, M.E.; Adham, N.; Zgombick, J.M.; Cohen, M.L.; Branchek, T.A.; Phebus, L.A., 1997:
5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs

Rasmusson, A.M.; Goldstein, L.E.; Deutch, A.Y.; Bunney, B.S.; Roth, R.H., 1994:
5-HT-1a agonist racemic 8-OH-DPAT modulates basal and stress-induced changes in medial prefrontal cortical dopamine

Yan, W.; Wilson, C.C.; Haring, J.H., 1997:
5-HT-1a receptors mediate the neurotrophic effect of serotonin of developing dentate granule cells

Nyberg, S.; Farde, L.; Eriksson, L.; Halldin, C.; Eriksson, B., 1993:
5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone

Kapur, Shitij, 1996:
5-HT-2 antagonism and EPS benefits: Is there a causal connection?

Panocka, I.; Ciccocioppo, R.; Pomperi, P.; Massi, M., 1993:
5-HT2 receptor antagonists do not reduce ethanol preference in Sardinian alcohol-preferring (sP) rats

Pires, J.G.; Silva, S.R.; Futuro-Neto, H.A., 1994:
5-HT2 receptor blockade by ICI 170,809 does not affect the inhibitory effect of the 5-HT1A receptor ligand gepirone on neuroleptic-induced catalepsy

Myers, R.D.; Lankford, M.F.; Bjork, A., 1993:
5-HT-2 receptor blockade by amperozide suppresses ethanol drinking in genetically preferring rats

Nimgaonkar, V.L.; Zhang, X.R.; Brar, J.S.; DeLeo, M.; Ganguli, R., 1996:
5-HT2 receptor gene locus: association with schizophrenia or treatment response not detected

Morilak, D.A.; Ciaranello, R.D., 1993:
5-HT-2 receptor immunoreactivity on cholinergic neurons of the pontomesencephalic tegmentum shown by double immunofluorescence

McLean, J.H.; Darby-King, A.; Hodge, E., 1996:
5-HT2 receptor involvement in conditioned olfactory learning in the neonate rat pup

Ramirez, M.J.; Cenarruzabeitia, E.; Lasheras, B.; Del Rio, J., 1997:
5-HT-2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices

Lalley, P.M.; Bischoff, A.M.; Schwarzacher, S.W.; Richter, D.W., 1995:
5-HT2 receptor-controlled modulation of medullary respiratory neurones in the cat

Huan, X.; Nichols, D.E., 1993:
5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits

Szarek, J.L.; Zhang, J.Z.; Gruetter, C.A., 1993:
5-HT2 receptors augment cholinergic nerve-mediated contraction of rat bronchi

Schmidt, C., J.; Fadayel, G., M.; Sullivan, C., K.; Taylor, V., L., 1992:
5-HT-2 receptors exert a state-dependent regulation of dopaminergic function: Studies with MDL 100907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine

Govitrapong, P.; Limthavon, C.; Srikiatkhachorn, A., 1992:
5-HT2 serotonin receptor on blood platelet of migraine patients

Tavakoli, R.; Frossard, N., 1995:
5-HT-2-mediated bronchial responses after syngeneic lung transplantation in the rat

Yamazaki, J.; Fukuda, H.; Nagao, T.; Ono, H., 1992:
5-HT2/5-HT1C receptor-mediated facilitatory action on unit activity of ventral horn cells in rat spinal cord slices

Arranz, M., J.; Erdmann, J.; Kirov, G.; Rietschel, M.; Sodhi, M.; Albus, M.; Ball, D.; Maier, W.; Davies, N.; Franzek, E.; Abusaad, I.; Weigelt, B.; Murray, R.; Shimron-Abarbanell, D.; Kerwin, R.; Propping, P.; Sham, P.; Nothen, M., M.; Collier, D., A., 1997:
5-HT-2A receptor and bipolar affective disorder: Association studies in affected patients

Cozzi, N.V.; Nichols, D.E., 1996:
5-HT2A receptor antagonists inhibit potassium-stimulated gamma-aminobutyric acid release in rat frontal cortex

Bartrup, J.T.; Newberry, N.R., 1994:
5-HT2A receptor-mediated outward current in C6 glioma cells is mimicked by intracellular IP3 release

Vaidya, V.A.; Marek, G.J.; Aghajanian, G.K.; Duman, R.S., 1997:
5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex

Kulikov, A.V.; Avgustinovich, D.F.; Kolpakov, V.G.; Maslova, G.B.; Popova, N.K., 1995:
5-HT-2A serotonin receptors in the brain of rats and mice hereditarily predisposed to catalepsy

Ullmer, C.; Boddeke, H.G.W.M.; Schmuck, K.; Lubbert, H., 1996:
5-HT-2B receptor-mediated calcium release from ryanodine-sensitive intracellular stores in human pulmonary artery endothelial cells

Fiorella, D.; Helsley, S.; Rabin, R.A.; Winter, J.C., 1995:
5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine

Millan, M., J.; Peglion, J.-Louis; Lavielle, G.; Perrin-Monneyron, S., 1997:
5-HT-2C receptors mediate penile erections in rats: Actions of novel and selective agonists and antagonists

King, G.R.; Xue, Z.; Calvi, C.; Ellinwood, E.H.Jr, 1995:
5-HT-3 agonist-induced dopamine overflow during withdrawal from continuous or intermittent cocaine administration

Tuladhar, B.R.; Costall, B.; Naylor, R.J., 1996:
5-HT-3 and 5-HT-4 receptor-mediated facilitation of the emptying phase of the peristaltic reflex in the marmoset isolated ileum

Briejer, M.R.; Schuurkes, J.A.J., 1996:
5-HT-3 and 5-HT-4 receptors and cholinergic and tachykininergic neurotransmission in the guinea-pig proximal colon

Kilpatrick, G.J.; Hagan, R.M.; Gale, J.D., 1995:
5-HT-3 and 5-HT-4 receptors in terminal regions of the mesolimbic system

Santiago, M.; Machado, A.; Cano, J., 1995:
5-HT-3 receptor agonist induced carrier-mediated release of dopamine in rat striatum in vivo

Goethert, M.; Hamon, M.; Barann, M.; Boenisch, H.; Gozlan, H.; Laguzzi, R.; Metzenauer, P.; Nickel, B.; Szelenyi, I., 1995:
5-HT-3 receptor antagonism by anpirtoline, a mixed 5-HT-1 receptor agonist/5-HT-3 receptor antagonist

Coccaro, E.F.; Kavoussi, R.J.; Cooper, T.B.; Hauger, R., 1996:
5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response to d-fenfluramine challenge in healthy human subjects

Kankaanpaa, A.; Lillsunde, P.; Ruotsalainen, M.; Ahtee, L.; Seppala, T., 1996:
5-HT-3 receptor antagonist MDL 72222 dose-dependently attenuates cocaine- and amphetamine-induced elevations of extracellular dopamine in the nucleus accumbens and the dorsal striatum

Bienkowski, P.; Kuca, P.; Piasecki, J.; Kostowski, W., 1997:
5-HT-3 receptor antagonist, tropisetron, does not influence ethanol-induced conditioned taste aversion and conditioned place aversion

Svingos, A.L.; Hitzemann, R., 1992:
5-HT-3 receptor antagonists block cocaine-induced locomotion via a PCPA-sensitive mechanism

Cervo, L.; Pozzi, L.; Samanin, R., 1996:
5-HT-3 receptor antagonists do not modify cocaine place conditioning or the rise in extracellular dopamine in the nucleus accumbens of rat

Batsche, K.; Granoff, M.I.; Wang, R.Y., 1992:
5-HT-3 receptor antagonists fail to block the suppressant effect of cocaine on the firing rate of A10 dopamine neurons in the rat

Ossi, M.; Anderson, E.; Freeman, A., 1996:
5-HT3 receptor antagonists in the control of cisplatin-induced delayed emesis

Pei, Q.; Zetterstroem, T.; Leslie, R.A.; Graham Smith, D.G., 1993:
5-HT-3 receptor antagonists inhibit morphine-induced stimulation of mesolimbic dopamine release and function in the rat

Hayashi, H.; Miwa, Y.; Miki, I.; Ichikawa, S.; Yoda, N.; Ishii, A.; Kono, M.; Suzuki, F., 1992:
5-HT-3 receptor antagonists: 1. New quinoline derivatives

Hayashi, H.; Miwa, Y.; Ichikawa, S.; Yoda, N.; Miki, I.; Ishii, A.; Kono, M.; Yasuzawa, T.; Suzuki, F., 1993:
5-HT3 receptor antagonists. 2. 4-Hydroxy-3-quinolinecarboxylic acid derivatives

Kishibayashi, N.; Miwa, Y.; Hayashi, H.; Ishii, A.; Ichikawa, S.; Nonaka, H.; Yokoyama, T.; Suzuki, F., 1993:
5-HT-3 receptor antagonists: 3. Quinoline derivatives which may be effective in the therapy of irritable bowel syndrome

Roila, F.; Ballatori, E.; Tonato, M.; Del-Favero, A., 1997:
5-HT-3 receptor antagonists: Differences and similarities

Nishio, H.; Kohno, Y.; Fujii, A.; Negishi, Y.; Inoue, A.; Nakata, Y., 1996:
5-HT-3 receptor blocking properties of the antiparkinsonian agent, talipexole

Messori, E.; Candura, S.M.; Coccini, T.; Balestra, B.; Tonini, M., 1995:
5-HT-3 receptor involvement in descending reflex relaxation in the rabbit isolated distal colon

Johnson, R.M.; Inouye, G.T.; Eglen, R.M.; Wong, E.H.F., 1993:
5-HT-3 receptor ligands lack modulatory influence of acetylcholine release in rat entorhinal cortex

Matell, M.S.; King, G.R., 1997:
5-HT-3 receptor mediated dopamine release in the nucleus accumbens during withdrawal from continuous cocaine

King, G.R.; Joyner, C.M.; Ellinwood, E.H.Jr, 1994:
5-HT-3 receptor modulation of behavior during withdrawal from continuous or intermittent cocaine

Kostowski, W., 1996:
5-HT3 receptors and central effects of ethanol

Rizzo, C.A.; Kreutner, W.; Chapman, R.W., 1993:
5-HT-3 receptors augment neuronal, cholinergic contractions in guinea pig trachea

Desai, K.M.; Warner, T.D.; Vane, J.R., 1994:
5-HT-3 receptors do not mediate vagally-induced relaxation or contraction of the isolated stomach of the guinea-pig

Barann, M.; Goethert, M.; Boenisch, H.; Dybek, A.; Urban, B.W., 1997:
5-HT-3 receptors in outside-out patches of N1E-115 neuroblastoma cells: Basic properties and effects of pentobarbital

Kidd, E.J.; Laporte, A.M.; Langlois, X.; Fattaccini, C.M.; Doyen, C.; Lombard, M.C.; Gozlan, H.; Hamon, M., 1993:
5-HT-3 receptors in the rat central nervous system are mainly located on nerve fibres and terminals

Maswood, N.; Caldarola Pastuszka, M.; Uphouse, L., 1997:
5-HT-3 receptors in the ventromedial nucleus of the hypothalamus and female sexual behavior

Blier, P.; Monroe, P., J.; Bouchard, C.; Smith, D., L.; Smith, D., J., 1993:
5-HT-3 receptors which modulate (tritiated) 5-HT release in the guinea pig hypothalamus are not autoreceptors

Gyermek, L., 1995:
5-HT3 receptors: pharmacologic and therapeutic aspects

Edwards, E.; Hampton, E.; Ashby, C., R.; Zhang, J.; Wang, R., Y., 1996:
5-HT-3-like receptors in the rat medial prefrontal cortex: Further pharmacological characterization

Mclean, P.G.; Coupar, I.M., 1995:
5-HT-4 receptor antagonist affinities of SB207710, SB205008, and SB203186 in the human colon, rat oesophagus, and guinea-pig ileum peristaltic reflex

Gaster, L.M.; Wyman, P.A.; Ellis, E.S.; Brown, A.M.; Young, T.J., 1994:
5-HT-4 receptor antagonists: Oxazolo, oxazino and oxazepino(3,2-a)indole derivatives

Costall, B.; Naylor, R.J.; Tuladhar, B.R., 1993:
5-HT-4 receptor mediated facilitation of the emptying phase of the peristaltic reflex in the guinea-pig isolated ileum

Hegde, S.S.; Wong, A.G.; Perry, M.R.; Ku, P.; Moy, T.M.; Loeb, M.; Eglen, R.M., 1995:
5-HT-4 receptor mediated stimulation of gastric emptying in rats

Consolo, S.; Arnaboldi, S.; Giorgi, S.; Russi, G.; Ladinsky, H., 1994:
5-HT4 receptor stimulation facilitates acetylcholine release in rat frontal cortex

Ge, J.; Barnes, N.M., 1996:
5-HT-4 receptor-mediated modulation of 5-HT release in the rat hippocampus in vivo

Letty, S.; Child, R.; Dumuis, A.; Pantaloni, A.; Bockaert, J.; Rondouin, G., 1997:
5-HT-4 receptors improve social olfactory memory in the rat

Cohen, M.L.; Susemichel, A.D.; Bloomquist, W.; Robertson, D.W., 1994:
5-HT4 receptors in rat but not guinea pig, rabbit or dog esophageal smooth muscle

Teitler, M.; Scheick, C.; Howard, P.; Sullivani, J., E.I.; Iwamura, T.; Glennon, R., A., 1997:
5-HT-5A serotonin receptor binding: A preliminary structure-affinity investigation

Sebben, M.; Ansanay, H.; Bockaert, J.; Dumuis, A., 1994:
5-HT6 receptors positively coupled to adenylyl cyclase in striatal neurones in culture

Ying, S.W.ng; Rusak, B., 1997:
5-HT-7 receptors mediate serotonergic effects on light-sensitive suprachiasmatic nucleus neurons

Eison, A.S.; Wright, R.N.; Freeman, R.P.; Gylys, J.A., 1993:
5-HT-dependent myoclonus in guinea pigs: mediation through 5-HT1A-5-HT2 receptor interaction

Graf, S.; Sarna, S.K., 1996:
5-HT-induced jejunal motor activity: enteric locus of action and receptor subtypes

Briejer, M., R.; Akkermans, L., M.A.; Meulemans, A., L.; Lefebvre, R., A.; Schuurkes, J., A.J., 1995:
5-HT-induced neurogenic relaxations of the guinea-pig proximal colon: Investigation into the role of ATP and VIP in addition to nitric oxide

Bentue Ferrer, D.; Reymann, J.M.chel; Rousselle, J.C.aude; Massot, O.; Bourin, M.; Allain, H.; Fillion, G., 1998:
5-HT-moduline, a 5-HT1B/1D receptor endogenous modulator, interacts with dopamine release measured in vivo by microdialysis

Kumasegawa, T.; Arakawa, O., 1995:
5-HT1-A receptor agonist and 5-HT1-B receptor agonist effect on single and paired rats move speed

Diouf, O.; Carato, P.; Depreux, P.; Bonte, J.P.; Caignard, D.H.; Guardiola Lemaitre, B.; Rettori, M.C.; Belzung, C.; Lesieur, D., 1997:
5-HT1A and 5-HT2A ligands with anxiolytic and antipanic-like properties

Leone, M.; Attanasio, A.; Croci, D.; Ferraris, A.; D'Amico, D.; Grazzi, L.; Nespolo, A.; Bussone, G., 1998:
5-HT1A receptor hypersensitivity in migraine is suggested by the m-chlorophenylpiperazine test

Edagawa, Y.; Saito, H.; Abe, K., 1998:
5-HT1A receptor-mediated inhibition of long-term potentiation in rat visual cortex

Nagaoka, I.; Sasa, M.; Yamawaki, S., 1998:
5-HT1A receptor-mediated inhibition of nucleus accumbens neurons activated by stimulation of parafascicular nucleus of thalamus

Castro, M.E.ena; Pascual, J.; Romon, T.; Berciano, J.; Figols, J.; Pazos, A., 1998:
5-HT1B receptor binding in degenerative movement disorders

Maassenvandenbrink, A.; Vergouwe, M.N.; Ophoff, R.A.; Saxena, P.R.; Ferrari, M.D.; Frants, R.R., 1998:
5-HT1B receptor polymorphism and clinical response to sumatriptan

Ishida, T.; Hirata, K.; Sakoda, T.; Kanazawa, K.; Kawashima, S.; Akita, H.; Yokoyama, M., 1998:
5-HT1Dbeta receptor mediates the supersensitivity of isolated coronary artery to serotonin in variant angina

Kapur, S.; Zipursky, R.B.; Remington, G.; Jones, C.; DaSilva, J.; Wilson, A.A.; Houle, S., 1998:
5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation

Brandenberger, G.; Luthringer, R.; Muller, G.; Gronfier, C.; Schaltenbrand, N.; Macher, J.P.; Muzet, A.; Follenius, M., 1996:
5-HT2 receptors are partially involved in the relationship between renin release and delta relative power

Holmes, C.; Arranz, M.J.; Powell, J.F.; Collier, D.A.; Lovestone, S., 1998:
5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease

Ninan, I.; Kulkarni, S.K., 1998:
5-HT2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion

Tokunaga, A.; Saika, M.; Senba, E., 1998:
5-HT2A receptor subtype is involved in the thermal hyperalgesic mechanism of serotonin in the periphery

Choi, D.S.; Ward, S.J.; Messaddeq, N.; Launay, J.M.; Maroteaux, L., 1997:
5-HT2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardiac cells

Martin, J.R.; Bos, M.; Jenck, F.; Moreau, J.L.; Mutel, V.; Sleight, A.J.; Wichmann, J.; Andrews, J.S.; Berendsen, H.H.G.; Broekkamp, C.L.E.; Ruigt, G.S.F.; Koehler, C.; Van Delft, A.M.L., 1998:
5-HT2C receptor antagonists: Pharmacological characteristics and therapeutic potential

Perrone, R.; Berardi, F.; Colabufo, N., A.; Leopoldo, M.; Tortorella, V., 1997:
5-HT3 and 5-HT4 receptor affinities of naphtho(1,2-d)thiazole derivatives with various basic side chains

Rival, Y.; Hoffmann, R.; Didier, B.; Rybaltchenko, V.; Bourguignon, J.J.; Wermuth, C.G., 1998:
5-HT3 antagonists derived from aminopyridazine-type muscarinic M1 agonists

Genova, L.M.; Hyman, S.E., 1998:
5-HT3 receptor activation is required for induction of striatal c-Fos and phosphorylation of ATF-1 by amphetamine

Rudd, J.A.; Ngan, M.P.; Wai, M.K., 1998:
5-HT3 receptors are not involved in conditioned taste aversions induced by 5-hydroxytryptamine, ipecacuanha or cisplatin

Volpi, R.; Chiodera, P.; Giuliani, N.; Capretti, L.; Caffarri, G.; Magotti, M.G.; Coiro, V., 1998:
5-HT3 serotonergic receptor mediation of hypoglycemia-induced arginine-vasopressin but not oxytocin secretion in normal men

Reavill, C.; Hatcher, J.P.; Lewis, V.A.n; Sanger, G.J.; Hagan, J., 1998:
5-HT4 receptor antagonism does not affect motor and reward mechanisms in the rat

Thorre, K.; Ebinger, G.; Michotte, Y., 1998:
5-HT4 receptor involvement in the serotin-enhanced dopamine efflux from the substantia nigra of the freely moving rat: A microdialysis study

Graf, S.; Sarna, S., K., 1997:
5-HT-induced colonic contractions: enteric locus of action and receptor subtypes

Bourin, M.; Hascoet, M.; Deguiral, P., 1996:
5-HTP induced diarrhea as a carcinoid syndrome model in mice?

Cory, J.G.; Downes, D.L.; Ng, C.Y.; Belt, J.A., 1992:
5-hexyl-2'-deoxyuridine inhibition of nucleoside transport in L1210 cells

Kraevskii, A.A.; Tarusova, N.; Zhu, K.Y.; Vidal, P.; Chu, T.C.ao; Baron, P.; Pol'ski, B.; Yang, S.Y.n; Matulich Adamich, Y., 1992:
5-Hydrogen phosphonates and 5-methylphosphonates of sugar modified nucleosides as potential anti-HIV agents

Yang, Z.; Wrona, M., Z.; Dryhurst, G., 1997:
5-Hydroxy-3-ethylamino-2-oxindole is not formed in rat brain following a neurotoxic dose of methamphetamine: Evidence that methamphetamine does not induce the hydroxyl radical-mediated oxidation of serotonin

Lorenzen, K.; Anke, T.; Konetschny-Rapp, S.; Scheuer, W., 1995:
5-hydroxy-3-vinyl-2(5H)-furanone--a new inhibitor of human synovial phospholipase A2 and platelet aggregation from fermentations of a Calyptella species (basidiomycetes)

Hofmann, P.; Loimer, N.; Chaudhry, H.R.; Pfersmann, D.; Schmid, R.; Wieselmann, G., 1996:
5-Hydroxy-indolacetic-acid (5-HIAA) serum levels in depressive patients and ECT

Bystrykh, L., V.; Herrema, J., K.; Kruizinga, W.; Kellogg, R., M., 1997:
5-Hydroxyaloesaponarin II, a minor blue pigment in an actinorhodin-negative mutant of Streptomyces coelicolor A3(2)

Rauwald, H., W.; Beil, A., 1993:
5-Hydroxyaloin A in the genus Aloe: Thin layer chromatographic screening and high performance liquid chromatographic determination

Ohkuma, H.; Tomita, K.; Hoshino, Y.; Suzuki, K.; Hasegawa, M.; Sawada, Y.; Konishi, M.; Hook, D.J.; Oki, T., 1993:
5-Hydroxyanthranilic acid derivatives as potent 5-lipoxygenase inhibitors

Sakamoto, K.; Yamazaki, J.; Nagao, T., 1998:
5-Hydroxydecanoate selectively reduces the initial increase in extracellular K+ in ischemic guinea-pig heart

Groves, P.M.; Linder, J.C.; Young, S.J., 1994:
5-hydroxydopamine-labeled dopaminergic axons: three-dimensional reconstructions of axons, synapses and postsynaptic targets in rat neostriatum

O'flaherty, J.T.; Rossi, A.G., 1993:
5-Hydroxyeicosatetraenoate stimulates neutrophils by a stereospecific, G protein-linked mechanism

Edwin, S.S.; Romero, R.J.; Munoz, H.; Branch, D.W.; Mitchell, M.D., 1996:
5-Hydroxyeicosatetraenoic acid and human parturition

Edwin, S.S.; LaMarche, S.L.; Thai, D.; Branch, D.W.; Mitchell, M.D., 1993:
5-Hydroxyeicosatetraenoic acid biosynthesis by gestational tissues: effects of inflammatory cytokines

Kooyman, A.R.; Van Hooft, J.A.; Vijverberg, H.P.M., 1993:
5-Hydroxyindole slows desensitization of the 5-HT-3 receptor-mediated ion current in N1E-115 neuroblastoma cells

Cespuglio, R.; Burlet, S.; Faradji-Prevautel, H., 1998:
5-Hydroxyindoles compounds and nitric oxide voltammetric detection in the rat brain: Changes occurring throughout the sleep-wake cycle

Faure, H.; Coudray, C.; Mousseau, M.; Ducros, V.; Douki, T.; Bianchini, F.; Cadet, J.; Favier, A., 1996:
5-Hydroxymethyluracil excretion, plasma TBARs and plasma antioxidant vitamins in adriamycin-treated patients

Putra, S.-Rosa; Charon, L.; Danielsen, K.; Pale-Grosdemange, C.; Lois, L.-Maria; Campos, N.; Boronat, A.; Rohmer, M., 1998:
5-Hydroxypentane-2,3-dione (laurencione), a bacterial metabolite of 1-deoxy-D-threo-pentulose

Purmal, A.A.; Kow, Y.W.; Wallace, S.S., 1994:
5-Hydroxypyrimidine deoxynucleoside triphosphates are more efficiently incorporated into DNA by exonuclease-free Klenow fragment than 8-oxopurine deoxynucleoside triphosphates

Fozard, J., R.; Kalkman, H., O., 1994:
5-Hydroxytryptamine (5-HT) and the initiation of migraine: New perspectives

Pertz, H., 1993:
5-Hydroxytryptamine (5-HT) contracts the guinea-pig isolated iliac artery via 5-HT-1-like and 5-HT-2 receptors

Cocks, T.M.; Arnold, P.J., 1992:
5-Hydroxytryptamine (5-HT) mediates potent relaxation in the sheep isolated pulmonary vein via activation of 5-HT-4 receptors

Reynold, G.P.; Mason, S.L.; Meldrum, A.; De-Keczer, S.; Parnes, H.; Eglen, R.M.; Wong, E.H.F., 1995:
5-Hydroxytryptamine (5-HT)-4 receptors in post mortem, human brain tissue: Distribution, pharmacology and effects of neurodegenerative diseases

Fiorucci, S.; Santucci, L.; Morelli, A., 1993:
5-Hydroxytryptamine 3-receptor antagonist modulates gallbladder emptying and motilin release induced by erythromycin

Schoeffter, P.; Pfeilschifter, J.; Bobirnac, I., 1995:
5-Hydroxytryptamine 5-HT-1B receptors inhibiting cyclic AMP accumulation in rat renal mesangial cells

Schoeffter, P.; Bobirnac, I., 1995:
5-Hydroxytryptamine 5-HT-1D receptors mediating inhibition of cyclic AMP accumulation in Madin-Darby canine kidney (MDCK) cells

Villalon, C.M.; Contreras, J.; Juan, E.R.mirez San; Castillo, C.; Perusquia, M.; Lopez Munoz, F.J.; Terron, J.A., 1995:
5-Hydroxytryptamine Inhibits Pressor Responses To Preganglionic Sympathetic Nerve Stimulation In Pithed Rats

Davy, M.; Grandcourt, O.; Midol-Monnet, M.; Cohen, Y., 1997:
5-Hydroxytryptamine and beta-adrenoceptors in rat isolated atria

Gorard, D.A.; Libby, G.W.; Farthing, M.J., 1994:
5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake

Ho, M.Y.; Al-Zahrani, S.S.A.; Al-Ruwaitea, A.S.A.; Bradshaw, C.M.; Szabadi, E., 1998:
5-Hydroxytryptamine and impulse control: Prospects for a behavioural analysis

Hindle, A.T.; Hopkins, P.M., 1998:
5-Hydroxytryptamine causes depression of twitch height in the partially curarized rat phrenic nerve hemidiaphragm preparation

Karlsson, C.; Bodelsson, G.; Bodelsson, M.; Stjernquist, M., 1997:
5-Hydroxytryptamine contracts human uterine artery smooth muscle predominantly via 5-HT2 receptors

Ma, R.C.; Szurszewski, J.H., 1996:
5-Hydroxytryptamine depolarizes neurons of cat pancreatic ganglia

Loots, W.; D.C.erck, F., 1993:
5-Hydroxytryptamine dominates over thromboxane A2 in reducing collateral blood flow by activated platelets

Pickering, A.E.; Spanswick, D.; Logan, S.D., 1994:
5-Hydroxytryptamine evokes depolarizations and membrane potential oscillations in rat sympathetic preganglionic neurones

Takahashi, T.; Ward, J.K.; Tadjkarimi, S.; Yacoub, M.H.; Barnes, P.J.; Belvisi, M.G., 1995:
5-Hydroxytryptamine facilitates cholinergic bronchoconstriction in human and guinea pig airways

Norevall, L.I.ge; Matsson, L.; Forsgren, S., 1996:
5-Hydroxytryptamine immunoreactivity is detectable in sympathetic nerve fibres in rat oral tissues

Gajkowska, B.; Viron, A., 1995:
5-Hydroxytryptamine in hypothalamo-neurohypophysial system after ischemia; an ultrastructural immunogold study on the rat

Chojnacka-Wójcik, E., 1995:
5-Hydroxytryptamine in the central nervous system

Schoemaker, R.G.; Du, X.Y.; Bax, W.A.; Saxena, P.R., 1992:
5-Hydroxytryptamine increases contractile force in porcine right atrium but not in left ventricle

Flores, G.; Rosales, M.G.; Hernandez, S.; Sierra, A.; Aceves, J., 1995 :
5-Hydroxytryptamine increases spontaneous activity of subthalamic neurons in the rat

Humblot, N.; Esteve, L.; Burgun, C.; Aunis, D.; Zwiller, J., 1997:
5-Hydroxytryptamine induces TIS8/egr-1 and c-fos expression in PC12 cells. Involvement of tyrosine protein phosphorylation

Zhang, L.; Dyer, D., C.; Fiscus, R., R.; Grujic, Z.; Wang, X., 1995:
5-Hydroxytryptamine induces endothelium-independent relaxations of sheep pulmonary vein: Role of cyclic nucleotide

Plaza, M.A.; Arruebo, M.P.; Murillo, M.D., 1996:
5-Hydroxytryptamine induces forestomach hypomotility in sheep through 5-HT4 receptors

Tamaoki, J.; Chiyotani, A.; Takemura, H.; Konno, K., 1997:
5-Hydroxytryptamine inhibits Na absorption and stimulates Cl secretion across canine tracheal epithelial sheets

Licata, F.; L.V.lsi, G.; Ciranna, L.; Maugeri, G.; Santangelo, F., 1998:
5-Hydroxytryptamine modifies neuronal responses to glutamate in the red nucleus of the rat

Hindle, A.T.; Hopkins, P.M., 1998:
5-Hydroxytryptamine potentiates post-tetanic twitch responses in the rat phrenic nerve diaphragm preparation

Jansen, I.; Olesen, J.; Edvinsson, L., 1993:
5-Hydroxytryptamine receptor characterization of human cerebral, middle meningeal and temporal arteries: regional differences

Porter, R.J.; Mcallister Williams, R.H.mish; Lunn, B.S.; Young, A.H., 1998:
5-Hydroxytryptamine receptor function in humans is reduced by acute administration of hydrocortisone

Pierce, P.A.; Xie, G.X.; Levine, J.D.; Peroutka, S.J., 1996:
5-Hydroxytryptamine receptor subtype messenger RNAs in rat peripheral sensory and sympathetic ganglia: A polymerase chain reaction study

Saudou, F.; Hen, R., 1994:
5-Hydroxytryptamine receptor subtypes in vertebrates and invertebrates

Yang, C.-Mao; Yo, Y.-Ling; Hsieh, J.-Tsung; Ong, R., 1994:
5-Hydroxytryptamine receptor-mediated phosphoinositide hydrolysis in canine cultured tracheal smooth muscle cells

Maclean, M.R.; Sweeney, G.; Baird, M.; Mcculloch, K.M.; Houslay, M.; Morecroft, I., 1996:
5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats

Messori, E.; Rizzi, C.A.; Candura, S.M.; Lucchelli, A.; Balestra, B.; Tonini, M., 1995:
5-Hydroxytryptamine receptors that facilitate excitatory neuromuscular transmission in the guinea-pig isolated detrusor muscle

Schoeffter, P.; Waeber, C., 1994:
5-Hydroxytryptamine receptors with a 5-HT-6 receptor-like profile stimulating adenylyl cyclase activity in pig caudate membranes

Pattichis, K.; Louca, L., L.; Jarman, J.; Sandler, M.; Glover, V., 1995:
5-Hydroxytryptamine release from platelets by different red wines: Implications for migraine

Hwang, L.L.; Dun, N.J., 1998:
5-Hydroxytryptamine responses in immature rat rostral ventrolateral medulla neurons in vitro

Fischer, Y.; Thomas, J.; Kamp, J.; Jüngling, E.; Rose, H.; Carpéné; Kammermeier, H., 1995:
5-hydroxytryptamine stimulates glucose transport in cardiomyocytes via a monoamine oxidase-dependent reaction

Schoemaker, R.G.; Du, X.Y.; Bax, W.A.; Bos, E.; Saxena, P.R., 1993:
5-Hydroxytryptamine stimulates human isolated atrium but not ventricle

Hu, X.Q.n; Dyer, D.C., 1997:
5-Hydroxytryptamine stimulates phosphoinositide hydrolysis and contraction in the ovine umbilical artery

Mayer, S.E.; Sanders-Bush, E., 1994:
5-Hydroxytryptamine type 2A and 2C receptors linked to Na+/K+/Cl- cotransport

Coulie, B.; Tack, J.; Bouillon, R.; Peeters, T.; Janssens, J., 1998:
5-Hydroxytryptamine-1 receptor activation inhibits endocrine pancreatic secretion in humans

Bruinvels, A.T.; Palacios, J.M.; Hoyer, D., 1993:
5-Hydroxytryptamine-1 recognition sites in rat brain: Heterogeneity of non-5-hydroxytryptamine-1A/1C binding sites revealed by quantitative receptor autoradiography

Ebersole, B.J.; Diglio, C.A.; Kaufman, D.W.; Berg, K.A., 1993:
5-Hydroxytryptamine1-like receptors linked to increases in intracellular calcium concentration and inhibition of cyclic AMP accumulation in cultured vascular smooth muscle cells derived from bovine basilar artery

Cowen, D.S.; Molinoff, P.B.; Manning, D.R., 1997:
5-hydroxytryptamine1A receptor-mediated increases in receptor expression and activation of nuclear factor-kappaB in transfected Chinese hamster ovary cells

Lucas, J.J.; Segu, L.; Hen, R., 1997:
5-Hydroxytryptamine1B receptors modulate the effect of cocaine on c-fos expression: converging evidence using 5-hydroxytryptamine1B knockout mice and the 5-hydroxytryptamine1B/1D antagonist GR127935

Choppin, A.; O'Connor, S.E., 1994:
5-Hydroxytryptamine1D-like receptors mediate contraction of partially depolarized rabbit renal arteries

Miyahara, H.; Kawai, Y.; Ohhashi, T., 1994:
5-Hydroxytryptamine-2 and -4 receptors located on bovine isolated mesenteric lymphatics

Hansen, M.B.; Thorboll, J.E.; Skadhauge, E., 1994:
5-Hydroxytryptamine-2 and 5-hydroxytryptamine-3 receptors mediate serotonin-induced short-circuit current in pig jejunum

Goodnough, D.B.; Baker, G.B., 1994:
5-Hydroxytryptamine2 and beta-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination

Goudreau, J.L.; Lookingland, K.J.; Moore, K.E., 1994:
5-Hydroxytryptamine2 receptor-mediated regulation of periventricular-hypophysial dopaminergic neuronal activity and the secretion of alpha-melanocyte-stimulating hormone

Garnovskaya, M.N.; Nebigil, C.G.; Arthur, J.M.; Spurney, R.F.; Raymond, J.R., 1995:
5-Hydroxytryptamine2A receptors expressed in rat renal mesangial cells inhibit cyclic AMP accumulation

Watts, S.W.; Gilbert, L.; Webb, R.C., 1995:
5-Hydroxytryptamine2B receptor mediates contraction in the mesenteric artery of mineralocorticoid hypertensive rats

Cox, D.A.; Cohen, M.L., 1995:
5-Hydroxytryptamine2B receptor signaling in rat stomach fundus: role of voltage-dependent calcium channels, intracellular calcium release and protein kinase C

Berg, K.A.; Maayani, S.; Clarke, W.P., 1996:
5-hydroxytryptamine2C receptor activation inhibits 5-hydroxytryptamine1B-like receptor function via arachidonic acid metabolism

Banner, S.E.; Carter, M.; Sanger, G.J., 1995:
5-Hydroxytryptamine-3 receptor antagonism modulates a noxious visceral pseudoaffective reflex

Ashworth Preece, M.A.; Jarrott, B.; Lawrence, A.J., 1995:
5-Hydroxytryptamine-3 receptor modulation of excitatory amino acid release in the rat nucleus tractus solitarius

Wilmer, A.; Tack, J.; Coremans, G.; Janssens, J.; Peeters, T.; Vantrappen, G., 1993:
5-hydroxytryptamine-3 receptors are involved in the initiation of gastric phase-3 motor activity in humans

Ogle, C.W.; Hui, S.C.; Qiu, B.S.; Li, K.M., 1992:
5-Hydroxytryptamine3-receptor blockade protects against gastric mucosal damage in rats

Torres, G.E.; Arfken, C.L.; Andrade, R., 1996:
5-Hydroxytryptamine4 receptors reduce afterhyperpolarization in hippocampus by inhibiting calcium-induced calcium release

Inoue, A.; Hashimoto, T.; Hide, I.; Nishio, H.; Nakata, Y., 1997:
5-Hydroxytryptamine-facilitated release of substance P from rat spinal cord slices is mediated by nitric oxide and cyclic GMP

Karhula, T.; Soinila, S.; Lakomy, M.; Majewski, M.; Kaleczyk, J.; Happola, O., 1995:
5-Hydroxytryptamine-immunoreactive nerve fibers in the rat and porcine prevertebral sympathetic ganglia: Effect of precursor loading and relation to catecholaminergic neurons

Arima, T.; Mizuno, T.; Ohshima, Y.; Kitamura, Y.; Segawa, T.; Nomura, Y., 1997:
5-Hydroxytryptamine-induced Ca-2+-independent cGMP formation is mediated by nitric oxide in a nitric oxide synthase-independent manner in NG108-15 cells

Mizuno, R.; Ohhashi, T., 1995:
5-Hydroxytryptamine-induced NO-dependent relaxation in isolated strips of monkey popliteal lymph nodes

Dyer, S.M.; D.L.L.nde, I.S.; Frewin, D.B.; Head, R.J., 1998:
5-Hydroxytryptamine-induced contraction of the marmoset aorta is mediated by a 5-HT1-like receptor

Wang, J.X.a; Ikomi, F.; Ohhashi, T., 1997 :
5-Hydroxytryptamine-induced endothelium-dependent and -independent relaxations in isolated dog anterior spinal small arteries

Saxena, P.R.; Villalon, C.M.; Dhasmana, K.M.han; Verdouw, P.D., 1992:
5-Hydroxytryptamine-induced increases in left ventricular dP/dt-max does not suggest the presence of ventricular 5-HT-4 receptors in the pig

Hardcastle, J.; Hardcastle, P.T., 1998:
5-Hydroxytryptamine-induced secretion by rat jejunum in-vitro involves several 5-hydroxytryptamine receptor subtypes

Rueff, A.; Dray, A., 1992:
5-Hydroxytryptamine-induced sensitization and activation of peripheral fibres in the neonatal rat are mediated via different 5-hydroxytryptamine-receptors

Pierce, P.A.; Xie, G.X.; Peroutka, S.J.; Green, P.G.; Levine, J.D., 1995:
5-Hydroxytryptamine-induced synovial plasma extravasation is mediated via 5-hydroxytryptamine2A receptors on sympathetic efferent terminals

Yakubu, M.A.; Leffler, C.W., 1997:
5-Hydroxytryptamine-induced vasoconstriction after cerebral hematoma in piglets

Bianchi, C.; Ferraro, L.; Tanganelli, S.; Morari, M.; Spalluto, G.; Simonatao, M.; Beani, L., 1995:
5-Hydroxytryptamine-mediated effects of nicotine on endogenous GABA efflux from guinea-pig cortical slices

Carmena, M.J.; Camacho, A.; Solano, R.M.; Montalvo, L.; Garcia Lopez, E.; Arias, A.; Prieto, J.C., 1998:
5-Hydroxytryptamine1A receptor-mediated effects on adenylase cyclase and nitric oxide synthase activities in rat ventral prostate

Johnson, R.G.; Stevens, K.E.; Rose, G.M., 1998:
5-Hydroxytryptamine2 receptors modulate auditory filtering in the rat

Sarojini, R.; Nagabhushanam, R.; Fingerman, M., 1994:
5-Hydroxytryptaminergic control of testes development through the androgenic gland in the red swamp crayfish, Procambarus clarkii

Currie, P.J.; Coscina, D.V., 1998:
5-Hydroxytryptaminergic receptor agonists: effects on neuropeptide Y potentiation of feeding and respiratory quotient

Lescrinier, T.; Busson, R.; Rozenski, J.; Van Aerschot, A.; Herdewijn, P., 1995:
5-Hydroxytryptophan as a building block in oligopeptides using Fmoc/tBu SPPS

Laue, T., M.; Senear, D., F.; Eaton, S.; Ross, J.B.A.exander, 1993:
5-Hydroxytryptophan as a new intrinsic probe for investigating protein-DNA interactions by analytical ultracentrifugation: Study of the effect of DNA on self-assembly of the bacteriophage lambda cI repressor

Pappert, E., J.; Goetz, C., G.; Stebbins, G., T.; Belden, M.; Carvey, P., M., 1998:
5-Hydroxytryptophan-induced myoclonus in guinea pigs: Mediation through 5-HT1/2 receptor subtypes

D.S.hepper, J.; Zhou, X.; Velkeniers, B.; Hooghe-Peters, E.; Vanhaelst, L., 1994:
5-Hydroxytryptophan-stimulated prolactin levels in cafeteria diet fed rats: an in vivo evaluation of the central serotonergic tonus

Helander, A.; Beck, O.; Boysen, L., 1995:
5-Hydroxytryptophol conjugation in man: Influence of alcohol consumption and altered serotonin turnover

Moody, T.D.; Thomas, M.J.; Makinson, M.; O'dell, T.J., 1998:
5-Hz stimulation of CD3 pyramidal cell axons induces a beta-adrenergic modulated potentiation at synapses on CA1, but not CA3, pyramidal cells

Meiklejohn, B.I.; Rahman, N.A.; Roess, D.A.; Barisas, B.G.orge, 1997:
5-Iodonaphthyl-l-azide labeling of plasma membrane proteins adjacent to specific sites via energy transfer

Fluckiger-Isler, R.; Kux, E.; Walter, P., 1996:
5-Iodotubercidin and proglycosyn: A comparison of two glycogenic compounds in hepatocytes from fasted rats

Kim, K., D.; Lerner-Marmarosh, N.; Saraswati, M.; Kende, A., S.; Abood, L., G., 1994:
5-Isothiocyanonicotine: A high-affinity irreversible ligand for brain nicotinic receptors

Kiely, D., E.; Harry-O'kuru, R., E.; Morris, P., E.,. Jr.;; Morton, D., W.; Riordan, J., M., 1997:
5-Keto-mannose (D-lyxo-hexos-5-ulose) in aqueous solution-isomeric composition dominated by alpha/beta D-fructofuranose related structures

Woods, J.W.; Coffey, M.J.; Brock, T.G.; Singer, I.I.; Peters-Golden, M., 1995:
5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation

Mancini, J.A.; Li, C.; Vickers, P.J., 1993:
5-Lipoxygenase activity in the human pancreas

Bureau, M.F.; D.C.stro, C.M.B.rbosa; Cortese, C.; Bachelet, M.; Vargaftig, B.B.ris, 1997:
5-Lipoxygenase and endotoxin-induced microvascular albumin exchanges and leucocyte recruitment in guinea-pig lungs

Lepley, R.A.; Fitzpatrick, F.A., 1994:
5-Lipoxygenase contains a functional Src homology 3-binding motif that interacts with the Src homology 3 domain of Grb2 and cytoskeletal proteins

Bhatia, P.A.; Brooks, C.D.; Basha, A.; Ratajczyk, J.D.; Gunn, B.P.; Bouska, J.B.; Lanni, C.; Young, P.R.; Bell, R.L.; Carter, G.W., 1996:
5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones

Shizawa, T.; Ohmori, S.; Maeda, K.; Sakata, K.; Ishii, T.; Kamitani, T., 1996:
5-Lipoxygenase inhibitory and antihistamine activities of linetastine

Coffey, M.J.; Phare, S.M.; Kazanjian, P.H.; Peters-Golden, M., 1996:
5-Lipoxygenase metabolism in alveolar macrophages from subjects infected with the human immunodeficiency virus

Traianedes, K.; Dallas, M.R.; Garrett, I.R.; Mundy, G.R.; Bonewald, L.F., 1998:
5-Lipoxygenase metabolites inhibit bone formation in vitro

Light, D.B.; Mertins, T.M.; Belongia, J.A.; Witt, C.A., 1997:
5-Lipoxygenase metabolites of arachidonic acid regulate volume decrease by mudpuppy red blood cells

Gallwitz, W.E.; Mundy, G.R.; Lee, C.H.; Qiao, M.; Roodman, G.D.; Raftery, M.; Gaskell, S.J.; Bonewald, L.F., 1993:
5-Lipoxygenase metabolites of arachidonic acid stimulate isolated osteoclasts to resorb calcified matrices

Irvin, C.G.; Tu, Y.P.; Sheller, J.R.; Funk, C.D., 1997:
5-Lipoxygenase products are necessary for ovalbumin-induced airway responsiveness in mice

Wijkander, J.; O'Flaherty, J.T.; Nixon, A.B.; Wykle, R.L., 1995:
5-Lipoxygenase products modulate the activity of the 85-kDa phospholipase A2 in human neutrophils

Mancini, J.A.; Abramovitz, M.; Cox, M.E.; Wong, E.; Charleson, S.; Perrier, H.; Wang, Z.; Prasit, P.; Vickers, P.J., 1993:
5-Lipoxygenase-activating protein is an arachidonate binding protein

Abramovitz, M.; Wong, E.; Cox, M.E.; Richardson, C.D.; Li, C.; Vickers, P.J., 1993:
5-Lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase

Bonnaffe, D.; Simon, H., 1992:
5-Methoxypentono-1,4-lactones for (R)-2-hydroxy-5-methoxy-3-pentenoic acid obtained by bioreduction of the 2-oxo acid

Weyland, J.-Willem; Rooselaar, J.; Stern, A.-George, 1994:
5-Methoxypsoralen and 8-methoxypsoralen in sun cosmetics and fragrances: Analysis and market survey

Amici, L.A.; Gasparro, F.P., 1995:
5-Methoxypsoralen photoadduct formation: conversion of monoadducts to crosslinks

Molina-Carballo, A.; Munoz-Hoyos, A.; Martin-Garcia, J.A.; Uberos-Fernandez, J.; Rodriguez-Cabezas, T.; Acuna-Castroviejo, D., 1996:
5-Methoxytryptophol and melatonin in children: Differences due to age and sex

Zawilska, J., B.; Skene, D., J.; Nowak, J., Z., 1998:
5-Methoxytryptophol rhythms in the chick pineal gland: Effect of environmental lighting conditions

Christman, J.K.; Sheikhnejad, G.; Marasco, C.J.; Sufrin, J.R., 1995:
5-Methyl-2'-deoxycytidine in single-stranded DNA can act in cis to signal de novo DNA methylation

Uejima, Y.; Kokubo, M.; Oshida, J.; Kawabata, H.; Kato, Y.; Fujii, K., 1993:
5-Methyl-4H-3,1-benzoxazin-4-one derivatives: specific inhibitors of human leukocyte elastase

Herold, P.; Herzig, J.W.; Wenk, P.; Leutert, T.; Zbinden, P.; Fuhrer, W.; Stutz, S.; Schenker, K.; Meier, M.; Rihs, G., 1995:
5-Methyl-6-phenyl-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazocine-2,4-dione (BA 41899): representative of a novel class of purely calcium-sensitizing agents

Yesilada, A.; Gokhan, N.; Ozer, I.; Vural, K.; Erol, K., 1996:
5-Methyl-8-N-substituted-thiocarbamoyl-7,8-diazabicyclo(4.3.0) non-6-enes: Evaluation as BSAO inhibitors and pharmacological activity screening

Castro, G., D.; Diaz-Gomez, M., I.; Castro, J., A., 1996:
5-Methylcytosine attack by hydroxyl free radicals and during carbon tetrachloride promoted liver microsomal lipid peroxidation: structure of reaction products

Castro, G.D.; Stamato, C.J.; Castro, J.A., 1994:
5-Methylcytosine attack by tree radicals arising from bromotrichloromethane in a model system: Structures of reaction products

Counts, J., L.; Kaznowski, J., M.; Mcclain, R.M.chael; Goodman, J., I., 1997:
5-Methylcytosine is present in the 5' flanking region of Ha-ras in mouse liver and increases with ageing

Matias, W.G.; Creppy, E.E., 1998:
5-Methyldeoxycytosine as a biological marker of DNA damage induced by okadaic acid in vero cells

Wilkinson, A.M.; Anderson, D.N.; Abou Saleh, M.T.; Wesson, M.; Blair, J.A.; Farrar, G.; Leeming, R.J., 1994:
5-Methyltetrahydrofolate level in the serum of depressed subjects and its relationship to the outcome of ECT

Porta, C.; Moroni, M.; Epis, O.; Nastasi, G., 1996:
5-methyltetrahydrofolate or 5-formyltetrahydrofolic acid to modulate 5-fluorouracil's cytotoxic activity in vivo. A phase II study in patients with advanced colon cancer

Verhaar, M.C.; Wever, R.M.; Kastelein, J.J.; van Dam, T.; Koomans, H.A.; Rabelink, T.J., 1998:
5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia

Basyouni, W., M.; El-Bazza, Z., E., 1992:
5-Methylthiazolo(5,4-d)pyrimidines: I. Synthesis of newer thiazolopyrimidine derivatives with antimicrobial activity

Karwowski, J.P.; Jackson, M.; Rasmussen, R.R.; Humphrey, P.E.; Poddig, J.B.; Kohl, W.L.; Scherr, M.H.; Kadam, S.; McAlpine, J.B., 1993:
5-N-acetylardeemin, a novel heterocyclic compound which reverses multiple drug resistance in tumor cells. I. Taxonomy and fermentation of the producing organism and biological activity

Hochlowski, J.E.; Mullally, M.M.; Spanton, S.G.; Whittern, D.N.; Hill, P.; McAlpine, J.B., 1993:
5-N-acetylardeemin, a novel heterocyclic compound which reverses multiple drug resistance in tumor cells. II. Isolation and elucidation of the structure of 5-N-acetylardeemin and two congeners

Sur, P.; Chatterjee, S.P.; Roy, P.; Sur, B., 1995:
5-Nitrofuran derivatives of fatty acid hydrazides induce differentiation in human myeloid leukaemic cell lines

Loakes, D.; Brown, D.M., 1994:
5-Nitroindole as an universal base analogue

Studebaker, M.S.; Zhang, H.; Means, G.E., 1996:
5-Nitrosothio-2-nitrobenzoate: a reagent for the nitrosation of thiol groups in proteins

Ilieva, E.; Handjieva, N.; Spassov, S.; Popov, S., 1993:
5-O-Allosylantirrhinoside from Linaria species

Perez, M.; Pauwels, P.; Palmier, C.; John, G., W.; Valentin, J.-Pierre; Halazy, S., 1995:
5-O-carboxymethyl piperazide derivatives of serotonin: A new class of potent and selective 5-HT-1D receptor agonists

Fuchino, H.; Nakamura, H.; Wada, H.; Hakamatsuka, T.; Tanaka, N., 1997:
5-O-glucosylated kaempferols from the fern Dryopteris dickinsii

Brouwers, J.F.; Versluis, C.; van Golde, L.M.; Tielens, A.G., 1998:
5-Octadecenoic acid: evidence for a novel type of fatty acid modification in schistosomes

Kam, T.S.ok; Loh, K.Y.ng, 1993:
5-Oxo-19,20-dehydroervatamine from leaves of Tabernaemontana corymbosa

Powell, W.S.; Chung, D.; Gravel, S., 1995:
5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of human eosinophil migration

Schwenk, U.; Schröder, J.M., 1995:
5-Oxo-eicosanoids are potent eosinophil chemotactic factors. Functional characterization and structural requirements

O'Flaherty, J.T.; Kuroki, M.; Nixon, A.B.; Wijkander, J.; Yee, E.; Lee, S.L.; Smitherman, P.K.; Wykle, R.L.; Daniel, L.W., 1996:
5-Oxo-eicosanoids and hematopoietic cytokines cooperate in stimulating neutrophil function and the mitogen-activated protein kinase pathway

O'Flaherty, J.T.; Kuroki, M.; Nixon, A.B.; Wijkander, J.; Yee, E.; Lee, S.L.; Smitherman, P.K.; Wykle, R.L.; Daniel, L.W., 1996:
5-Oxo-eicosatetraenoate is a broadly active, eosinophil-selective stimulus for human granulocytes

O'flaherty, J.T.; Cordes, J.; Redman, J.; Thomas, M.J., 1993:
5-Oxoeicosatetraenoate, a potent human neutrophil stimulus

Mayatepek, E.; Hoffmann, G.F.; Larsson, A.; Becker, K.; Bremer, H.J., 1995:
5-Oxoprolinase deficiency associated with severe psychomotor developmental delay, failure to thrive, microcephaly and microcytic anaemia

Henderson, M.J.; Larsson, A.; Carlsson, B.; Dear, P.R.F., 1993:
5-Oxoprolinuria associated with 5-oxoprolinase deficiency; Further evidence that this is a benign disorder

Nekrasov, D.D.; Andreichikov, Yu, S.; Mardanova, L.G.; Kolla, V.E., 1993:
5-Phenacylidine-2-imino-4-oxazolidones: Synthesis and biological properties

Lowe, J.A.I.i; Hageman, D.L.; Drozda, S.E.; Mclean, S.; Bryce, D.K.; Crawford, R.T.; Zorn, S.; Morrone, J.; Bordner, J., 1994:
5-Phenyl-3-ureidobenzazepin-2-ones as cholecystokinin-B receptor antagonists

Jasko, M.; Shipitsin, A.; Shirokova, E.; Krayevsky, A.; Polsky, B.; Baron, P.; Maclow, C.; Ostrander, M.; O'hara, B., 1993:
5-Phosphonates of ribonucleosides and e-deoxyribonucleosides: Synthesis and antiviral activity

Olofsson, S.; Sjöblom, I.; Hellstrand, K.; Shugar, D.; Clairmont, C.; Hirschberg, C., 1993:
5-Propyl-2-deoxyuridine induced interference with glycosylation in herpes simplex virus infected cells. Nature of PdU-induced modifications of N-linked glycans

Goto, H.; Tenou, T.; Kudo, H.; Iwasaki, T.; Muramatsu, R.; Usui, M.; Wakamatsu, K.; Ito, S., 1998:
5-S-cysteinyldopa as a tumor marker for primary uveal malignant melanoma

Napolitano, A.; Memoli, S.; Nappi, A.J.; D'ischia, M.; Prota, G., 1996:
5-S-cysteinyldopa, a diffusible product of melanocyte activity is an efficient inhibitor of hydroxylation/oxidation reactions induced by the Fenton system

Ranise, A.; Bruno, O.; Bondavalli, F.; Schenone, S.; D'Amico, M.; Falciani, M.; Filippelli, W.; Rossi, F., 1994:
5-Substituted 2,3-dihydro-6-mercapto-1,3-diphenyl-2-thioxo-4(3H)-pyrimidinones and their 6-(acylthio) derivatives with platelet antiaggregating, antiinflammatory, antiarrhythmic, antihyperlipidemic and other activities

Chow, K.; Lai, R.; Holmes, J.M.; Wijono, M.; Wheeler, L.A.; Garst, M.E., 1996:
5-Substituted 3-thiophenesulfonamides as carbonic anhydrase inhibitors

Fossa, P.; Menozzi, G.; Schenone, P.; Mattioli, F., 1994:
5-substituted 4-isoxazoleacetic acids with analgesic activity

van der Wenden, E.M.; Carnielli, M.; Roelen, H.C.; Lorenzen, A.; von Frijtag Drabbe Künzel, J.K.; IJzerman, A.P., 1998:
5'-substituted adenosine analogs as new high-affinity partial agonists for the adenosine A1 receptor

Jaffar, M.; Naylor, M., A.; Robertson, N.; Lockyer, S., D.; Phillips, R., M.; Everett, S., A.; Adams, G., E.; Stratford, I., J., 1998:
5-Substituted analogues of 3-hydroxymethyl-5-aziridinyl-1-methyl-2-(1H-indole-4,7-dione)prop-2-en-1-ol(EO9, NSC 382459) and their regioisomers as hypoxia-selective agents: Structure-cytotoxicity in vitro

Kim, J., C.; Dong, E.-Soo; Parks, J.-Il; Bae, S.-Duk; Kim, S.-Hee, 1994:
5-Substituted pyrimidine acyclic nucleoside analogues 1-cyanomethyl- and 1-(4-cyanobutyl)-5-substituted uracils as candidate antitumor agents

Herdewijn, P.A.M.M., 1994:
5-Substituted-2'-deoxyuridines as anti-HSV-1 agents: Synthesis and structure activity relationship

Surh, Y.J.; Liem, A.; Miller, J.A.; Tannenbaum, S.R., 1994:
5-Sulfooxymethylfurfural as a possible ultimate mutagenic and carcinogenic metabolite of the Maillard reaction product, 5-hydroxymethylfurfural

Basyouni, W., M.; Haggag, B.; El-Sayed, A., S.; Hosni, H.; El-Bayouki, K., A.M., 1991:
5-Uredo-,5-thiouredo-thiazoles, thiazolo (5,4-d) pyrimidines and pyrimidinones with useful effect against Biomphalaria alexandrina snails

Higgins, R.M.; Bevan, D.J.; Vaughan, R.W.; Phillips, A.O.; Snowden, S.; Bewick, M.; Scoble, J.E.; Hendry, B.M., 1996:
5-year follow-up of patients successfully transplanted after immunoadsorption to remove anti-HLA antibodies

Faravelli, C.; Paterniti, S.; Scarpato, A., 1995:
5-Year prospective, naturalistic follow-up study of panic disorder

Ivarsson, S.A., 1996:
5-alpha reductase deficient men are fertile

Haning, R.V.; Tantravahi, U.; Zhao, Q.; Hackett, R.J.; Canick, J.A., 1996:
5alpha-reductase 1 and 2 expression and activity in human ovarian follicles, stroma and corpus luteum as compared to neonatal foreskin

Spera, G.; Lubrano, C., 1996:
5-alpha-Reductases and their inhibitors

Lemus, A.E.; Enríquez, J.; García, G.A.; Grillasca, I.; Pérez-Palacios, G., 1997:
5alpha-reduction of norethisterone enhances its binding affinity for androgen receptors but diminishes its androgenic potency

Jadhav, V., R.; Barawkar, D., A.; Natu, A., A.; Ganesh, K., N., 1997:
5-amido-(carboxyfluorescein)-2'-dU-oligonucleotides: Novel primers for fluorescent detection of PCR amplified DNA

Huber, S.C.; Kaiser, W.M., 1996:
5-aminoimidazole-4-carboxamide riboside activates nitrate reductase in darkened spinach and pea leaves

Van-Den-Boogert, J.; Van-Hillegersberg, R.; De-Rooij, F., W.M.; De-Bruin, R., W.F.; Edixhoven-Bosdijk, A.; Houtsmuller, A., B.; Siersema, P., D.; Wilson, J.H.P.ul; Tilanus, H., W., 1998:
5-aminolaevulinic acid-induced protoporphyrin IX accumulation in tissues: Pharmacokinetics after oral or intravenous administration

Dietel, W.; Fritsch, C.; Pottier, R.H.; Wendenburg, R., 1997:
5-aminolaevulinic-acid-induced formation of different porphyrins and their photomodifications

Hebeda, K.M.; Saarnak, A.E.; Olivo, M.; Sterenborg, H.J.C.M.; Wolbers, J.G., 1998:
5-aminolevulinic acid induced endogenous porphyrin fluorescence in 9L and C6 brain tumours and in the normal rat brain

Oteiza, P.I.; Bechara, E.J., 1993:
5-aminolevulinic acid induces lipid peroxidation in cardiolipin-rich liposomes

Chen, W.; Russell, C.S.; Murooka, Y.; Cosloy, S.D., 1994:
5-Aminolevulinic acid synthesis in Escherichia coli requires expression of hemA

Trallori, G.; d'Albasio, G.; Bardazzi, G.; Bonanomi, A.G.; Amorosi, A.; Del Carlo, P.; Palli, D.; Galli, M.; Pacini, F., 1994:
5-Aminosalicylic acid in pregnancy: clinical report

Hämling, J.; Raedler, A.; Helmchen, U.; Schreiber, S., 1997:
5-Aminosalicylic acid-associated renal tubular acidosis with decreased renal function in Crohn's disease

Dutka, N.M.; Zimenkovs'kyi, B.S.; Muzychenko, V.P.; Mazur, I.A.; Steblyuk, P.M., 1995:
5-arylidene derivatives of 2-ylidenazino-3-alpha-naphthylthiazolidone-4

Schinstine, M.; Iacovitti, L., 1997:
5-Azacytidine and BDNF enhance the maturation of neurons derived from EGF-generated neural stem cells

Spencer, D.L.; Caspary, W.J.; Hines, K.C.; Tindall, K.R., 1996:
5-Azacytidine-induced 6-thioguanine resistance at the gpt locus in AS52 cells: cellular response

Litt, M.D.; Hansen, R.S.; Hornstra, I.K.; Gartler, S.M.; Yang, T.P., 1997:
5-Azadeoxycytidine-induced chromatin remodeling of the inactive X-linked HPRT gene promoter occurs prior to transcription factor binding and gene reactivation

Bransová, J.; Uher, M.; Novotný, L.; Brtko, J., 1997:
5-benzyloxy-2-thiocyanatomethyl-4-pyranone, a novel heterocyclic compound: synthesis, structure determination and effects on neoplastic cell growth

Shah, W.A.; Qurishi, M.A.; Koul, S.K.; Dhar, K.L., 1996:
5-beta,24-alpha-stigmasta-8,22-dien-3-beta-OL, a sterol from Koelpinia linearis

Evershed, R.P.; Bethell, P.H.; Reynolds, P.J.; Walsh, N.J., 1997:
5-beta-Stigmastanol and related 5-beta-stanols as biomarkers of manuring: Analysis of modern experimental material and assessment of the archaeological potential

Yu, X.J.e; Waeber, C.; Castanon, N.; Scearce, K.; Hen, R.; Macor, J.E.; Chaveau, J.; Moskowitz, M.A., 1996:
5-carboxamido-tryptamine CP-122,288 and dihydroergotamine but not sumatriptan, CP-93, 129 and serotonin-5-O-carboxymethyl-glycyl-tyrosinamide block dural plasma protein extravasation in knockout mice that lack 5-hydroxytryptamine-1B receptors

Adam, D.; (Germany), C.-Study-Group; Hostalek, U.; Troester, K., 1995:
5-day cefixime therapy for bacterial pharyngitis and/or tonsillitis: Comparison with 10-day penicillin V therapy

Lemmich, E.; Adewunmi, C.O.; Furu, P.; Kristensen, A.; Larsen, L.; Olsen, C.E., 1996:
5-deoxyflavones from Parkia clappertoniana

Malanda, J.C.aude; Doutheau, A., 1993:
5-exo-dig radical cyclisation of 1,2,6-trideoxy-6-iodo-L-arabino-hex-1-ynitols derivatives

Liu, L.; Santi, D., V., 1994:
5-fluoro-2'-deoxycytidine 5'-monophosphate is a mechanism-based inhibitor of thymidylate synthase

Wong, P.C.; Ruderman, J.M.; Krupin, T.; Goldenfeld, M.; Rosenberg, L.F.; Shields, M.B.; Ritch, R.; Liebmann, J.M.; Gieser, D.K., 1994:
5-Fluorouracil after primary combined filtration surgery

Stuart, K.; Tessitore, J.; Huberman, M., 1996:
5-Fluorouracil and alpha-interferon in hepatocellular carcinoma

Look, K.Y.; Blessing, J.A.; Muss, H.B.; DeGeest, K., 1992:
5-fluorouracil and low-dose leucovorin in the treatment of recurrent epithelial ovarian carcinoma. A phase II trial of the Gynecologic Oncology Group

Look, K.Y.; Blessing, J.A.; Muss, H.B.; Partridge, E.E.; Malfetano, J.H., 1992:
5-fluorouracil and low-dose leucovorin in the treatment of recurrent squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group

Lamping, K.A.; Belkin, J.K., 1995:
5-fluorouracil and mitomycin C in Pseudophakic patients

Lemaire, L.; Arellano, M.; Malet-Martino, M.C.; Martino, R.; De-Forni, M., 1994:
5-fluorouracil cardiotoxicity: A question of formulation

Hill, S.R.; Bibby, M.C., 1994:
5-fluorouracil causes alterations in the pharmacokinetic profile of tauromustine in NMRI mice

Kumar, S.; Gupta, R.K.; Samal, N., 1995:
5-fluorouracil induced cardiotoxicity in albino rats

Müller, M.; Mader, R.M.; Steiner, B.; Steger, G.G.; Jansen, B.; Gnant, M.; Helbich, T.; Jakesz, R.; Eichler, H.G.; Blochl-Daum, B., 1997:
5-fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patients

Tausch-Treml, R.; Baumgart, F.; Ziessow, D.; Köpf-Maier, P., 1996:
5-Fluorouracil metabolism and cytotoxicity after pre-treatment with methotrexate or thymidine in human hypopharynx and colon carcinoma xenografts: a 19F-nuclear magnetic resonance spectroscopy study in vivo

Codacci-Pisanelli, G.; Franchi, F., 1994:
5-fluorouracil modulation in the chemotherapy of colorectal cancer

Breul, J.; Jakse, G.; Forster, G.; Lampel, A.; Rohani, A.; Hartung, R., 1997:
5-Fluorouracil versus folinic acid and 5-fluorouracil in advanced, hormone-resistant prostate cancer: a prospective randomized pilot trial

Khansur, T.; Allred, C.; Tavassoli, M., 1994:
5-Fluorouracil, adriamycin, and mitomycin C in adenocarcinoma of the esophagus or gastroesophageal junction tumors

Seitz, J.F.; Diaw, A.; Giovannini, M.; Perier, H.; Bouvernet, J., 1994:
5-fluorouracil, high-dose folinic acid and mitomycin C combination chemotherapy for the treatment of advanced digestive carcinomas

Wiebe, L., I.; Knaus, E., E.; Cheraghali, A.M.jid; Kumar, R.; Morin, K., W.; Wang, L., 1995:
5-halo-6-alkoxy-5,6-dihydro-pyrimidine nucleosides: Antiviral nucleosides or nucleoside prodrugs?

Friedrichs, G.S.; Abreu, J.N.lson; Black, S.C.; Chi, L.; Lucchesi, B.R., 1996:
5-hydroxydecanoate fails to attenuate ventricular fibrillation in a conscious canine model of sudden cardiac death

Bittleman, D.B.; Casale, T.B., 1995:
5-Hydroxyeicosatetraenoic acid (HETE)-induced neutrophil transcellular migration is dependent upon enantiomeric structure

Cooper, S.J.; Kelly, C.B.; King, D.J., 1992:
5-hydroxyindoleacetic acid in cerebrospinal fluid and prediction of suicidal behaviour in schizophrenia

Dringenberg, H., C.; Vanderwolf, C.H., 1996:
5-hydroxytryptamine (5-HT) agonists: Effects on neocortical slow wave activity after combined muscarinic and serotonergic blockade

Munoz Acedo, G.; Rodriguez Martin, E.; Puebla, L.; Arilla, E., 1997:
5-hydroxytryptamine decreases somatostatin receptors and somatostatin-responsive adenylyl cyclase in rat pancreatic acinar membranes

Pierce, P.A.; Xie, G.X.; Meuser, T.; Peroutka, S.J., 1997:
5-hydroxytryptamine receptor subtype messenger RNAs in human dorsal root ganglia: A polymerase chain reaction study

Bosker, F., J.; Donker, M., G.; Klompmakers, A., A.; Kurata, K.; Westenberg, H., G.M., 1994:
5-hydroxytryptamine release in dorsal hippocampus of freely moving rats: Modulation by pindolol

Assender, J.W.; Irenius, E.; Fredholm, B.B., 1997:
5-Hydroxytryptamine, angiotensin and bradykinin transiently increase intracellular calcium concentrations and PKC-alpha activity, but do not induce mitogenesis in human vascular smooth muscle cells

Helton, L.A.; Thor, K.B.; Baez, M., 1994:
5-hydroxytryptamine2A, 5-hydroxytryptamine2B, and 5-hydroxytryptamine2C receptor mRNA expression in the spinal cord of rat, cat, monkey and human

Ito, C.; Isobe, Y.; Tsuchida, K.; Higuchi, S., 1996:
5-Hydroxytryptamine3 receptor and regulation of gastric emptying in rats

Budhoo, M.R.; Harris, R.P.ul; Kellum, J.M., 1996:
5-hydroxytryptamine-induced Cl- transport is mediated by 5-HT-3 and 5-HT-4 receptors in the rat distal colon

Massot, O.; Rousselle, J.C.; Fillion, M.P.; Grimaldi, B.; Cloëz-Tayarani, I.; Fugelli, A.; Prudhomme, N.; Seguin, L.; Rousseau, B.; Plantefol, M.; Hen, R.; Fillion, G., 1996:
5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors

Shen, R.Y.; Andrade, R., 1998:
5-Hydroxytryptamine2 receptor facilitates GABAergic neurotransmission in rat hippocampus

Jakab, R.L.; Goldman-Rakic, P.S., 1998:
5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites

Grider, J.R.; Fox Orenstein, A.E.; Jin, J.G.ang, 1998:
5-hydroxytryptamine4 receptor againsts initiate the peristaltic reflex in human, rat, and guinea pig intestine

Gaynor, P.J.; Lookingland, K.J.; Tucker, H.A., 1995:
5-Hydroxytryptaminergic receptor-stimulated growth hormone secretion occurs independently of changes in peripheral somatostatin concentration

Taylor, K.C.; Geitzenauer, H.L., 1998:
5-kD zinc-binding protein accumulation in macrophylla-decline-affected citrus

Wright, L.; Tuder, R.M.; Wang, J.; Cool, C.D.; Lepley, R.A.; Voelkel, N.F., 1998:
5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension

Spanbroek, R.; Stark, H.J.ergen; Janssen Timmen, U.; Kraft, S.; Hildner, M.; Andl, T.; Bosch, F.X.ver; Fusenig, N.E.; Bieber, T.; Radmark, O.; Samuelsson, B.; Habenicht, A.J.R., 1998:
5-lipoxygenase expression in Langerhans cells of normal human epidermis

Piechele, G.; Colli, S.; Tremoli, E.; Maggi, A., 1993:
5-Lipoxygenase gene expression in HL60 cells during differentiation with DMSO

Mancini, J.A.; Prasit, P.; Coppolino, M.G.; Charleson, P.; Leger, S.; Evans, J.F.; Gillard, J.W.; Vickers, P.J., 1992:
5-Lipoxygenase-activating protein is the target of a novel hybrid of two classes of leukotriene biosynthesis inhibitors

Meury, Jean, 1993:
5-methoxyindole-2-carboxylic acid is a potent inhibitor of respiration and potassium ion transport in the archaebacterium Haloferax volcanii

Sarkar, R.; Haldar, C., 1997:
5-methoxyindoles (MEL, 5-MT and 5-MTP) induced biochemical changes in the pineal gland of Indian Palm Squirrel, Funambulus pennanti

Mauviard, F.; Raynaud, F.; Geoffriau, M.; Claustrat, B.; Pévet, P., 1995:
5-Methoxypsoralen inhibits 6-hydroxylation of melatonin in the rat

Candito, M.; Pringuey, D.; Lehert, P.; Drici, M.; Souetre, E.; Chambon, P.; Darcourt, G., 1993:
5-Methoxypsoralen: effect on the noradrenaline circadian rhythm of sleep-deprived subjects

Chen, Y.; Sierzputowska Gracz, H.; Guenther, R.; Everett, K.; Gris, P.F.A., 1993:
5-methylcytidine is required for cooperative binding of magnesium and a conformational transition at the anticodon stem-loop of yeast phenylalanine tRNA

Padia, Y.; Ariatti, M.; Jones, P., A., 1995:
5-methylcytosine and 5-azacytosine containing 25mer duplexes: Synthesis and investigation of their interaction with HeLa nuclear protein extracts

Lieb, M.; Rehmat, S., 1997:
5-methylcytosine is not a mutation hot spot in nondividing Escherichia coli

Rognstad, Robert, 1995:
5-oxoproline and carbamyl aspartate accumulation in rat hepatocytes

al-Obaid, A.M.; el-Subbagh, H.I.; Khodair, A.I.; Elmazar, M.M., 1996:
5-substituted-2-thiohydantoin analogs as a novel class of antitumor agents

Rex, D.K.; Cummings, O.W.; Helper, D.J.; Nowak, T.V.; Mcgill, J.M.; Chiao, G.Z.; Kwo, P.Y.; Gottlieb, K.T.; Ikenberry, S.O.; Gress, F.G.; Lehman, G.A.; Born, L.J., 1996:
5-year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons

Flanigan, R., C.; Reda, D., J.; Wasson, J., H.; Anderson, R., J.; Abdellatif, M.; Bruskewitz, R., C., 1998:
5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: A Department of Veterans Affairs Cooperative Study

Singireva, G.P.; Lyubchenko, P.N.; Shevchenko, V.A.; Novitskaya, N.N.; Borisova, N.M.; Dubinina, E.B.; Maslennikova, V.G., 1993:
5-year results of cytogenetic screening in liquidators of Chernobyl power accident consequences

Schuurman, P.R.; Troost, D.; Verbeeten, B.,. Jr.;; Bosch, D.A., 1997:
5-year survival and clinical prognostic factors in progressive supratentorial diffuse low-grade astrocytoma: A retrospective analysis of 46 cases

Catalona, W.J.; Smith, D.S., 1994:
5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer

Altin, S.; Cikrikçioğlu, S.; Morgül, M.; Koşar, F.; Ozyurt, H., 1997:
50 endobronchial tuberculosis cases based on bronchoscopic diagnosis

Scarfi, M.R.; Bersani, F.; Cossarizza, A.; Monti, D.; Zeni, O.; Lioi, M.B.; Franceschetti, G.; Capri, M.; Franceschi, C., 1993:
50 Hz AC sinusoidal electric fields do not exert genotoxic effects (micronucleus formation) in human lymphocytes

Riecher-Roessler, Anita, 1997:
50 Years after Manfred Bleuler: What do we know about late-onset schizophrenia today?

Mieslinger, Nikolaus, 1997:
50 years of bird observations at the river Inn between Wasserburg and Rosenheim

Shigemitsu, T.; Takeshita, K.; Shiga, Y.; Kato, M., 1993:
50-Hz magnetic field exposure system for small animals

Scarfi, M.R.; Zeni, O.; Della-Noce, M.; Di-Pietro, R.; Prisco, F.; Loi, M.B.; Franceschi, C.; Bersani, F., 1997:
50-Hz, 1-mT sinusoidal magnetic fields do not affect micronucleus frequency and cell proliferation in human lymphocytes from normal and Turner's syndrome subjects

Fujimoto, T.; Fujimura, K.; Noda, M.; Takafuta, T.; Shimomura, T.; Kuramoto, A., 1995:
50-kD integrin-associated protein does not detectably influence several functions of glycoprotein IIb-IIIa complex in human platelets

Szabó, G., 1995:
50-kb chromatin fragmentation in the absence of apoptosis

Fukatsu, A.; Sato, N.; Shimizu, H., 1996:
50-mile walking race suppresses neutrophil bactericidal function by inducing increases in cortisol and ketone bodies

Nagele, F.; Magos, A., 1997:
500 transcervical endometrial resections

Coplen, T.B.; Winograd, I.J.; Landwehr, J.M.; Riggs, A.C., 1994:
500,000-year stable carbon isotopic record from devils hole, nevada

Champney, W.S.; Burdine, R., 1996:
50S ribosomal subunit synthesis and translation are equivalent targets for erythromycin inhibition in Staphylococcus aureus

Korean Association, O.Biological Sciences, 1996:
50th Anniversary Meeting of the Korean Association of Biological Sciences, Korea, 1996

Pacific Coast Oyster Growers Association And National Shellfisheries Association, 1996:
50th Annual Meeting of the Pacific Coast Oyster Growers Association and National Shellfisheries Association, Lake Chelan, Washington, USA, September 22-24, 1996

Adachi, I.; Sugioka, Y.; Saiga, Y.; Namba, R.; Nakata, K.; Tatsu, Y.; Nishigaki, H.; Hiraishi, K.; Utsunomiya, K.; Sueyoshi, K., 1993:
512 x 2048 matrix whole body scintigraphy with laser imaging system

Pisciotta, A.V.; Konings, S.A., 1994:
51Cr release assay of clozapine-induced cytotoxicity: evidence for immunogenic mechanism

Yuan, Z.Y.; Rodela, H.; Hay, J.B.; Oreopoulos, D.; Johnston, M.G., 1994:
51Cr-RBCs and 125I-albumin as markers to estimate lymph drainage of the peritoneal cavity in sheep

Verma, M.; Ganguly, N.K.; Majumdar, S.; Walia, B.N., 1995:
51Cr-labelled ethylenediaminetetraacetic acid and D-xylose absorption test in Escherichia coli enterotoxin-induced diarrhoea in mice

Hillman, G.G.; Roessler, N.; Fulbright, R.S.; Pontes, J.E.; Haas, G.P., 1993:
51Cr-release assay adapted to a 96-well format sample reading

Anonymous, 1997:
51st Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research

American Academy, O.Oral Medicine, 1997:
51st Annual Meeting of the American Academy of Oral Medicine

American Academy, O.Oral And Maxillofacial Pathology, 1997:
51st Annual Meeting of the American Academy of Oral and Maxillofacial Pathology

American-Association-Of-Blood-Banks, 1998:
51st Annual Meeting of the American Association of Blood Banks (Philadelphia, Pennsylvania, USA; October 31-November 4, 1998)

Canadian Society, O.Otolaryngology, 1997:
51st Annual Meeting of the Canadian Society of Otolaryngology, Whistler, British Columbia, Canada, June 22-25, 1997

Eastern-Association-Of-Electroencephalographers, 1998:
51st Annual Meeting of the Eastern Association of Electroencephalographers (New York, New York, USA; March 8, 1997)

Japan Society, O.Medical Entomology And Zoology (Western Region)., 1997:
51st Annual Meeting of the Western Region of the Japan Society of Medical Entomology and Zoology, Tokushima, Japan, October 3-4, 1996

New Zealand Institute, O.Medical Laboratory Science, 1997:
51st Annual Scientific Meeting of the New Zealand Institute of Medical Laboratory Science, Wellington, New Zealand, August 1997

Deutsche-Gesellschaft-Fuer-Gynaekologie-Und-Geburtshilfe, 1996:
51st Congress of the Deutsche Gesellschaft fuer Gynaekologie und Geburtshilfe (German Society for Gynecology and Obstetrics), Dresden, Germany, October 1-5, 1996

Japanese Society, O.Parasitology, 1996:
51st West Japan Regional Meeting of the Japanese Society of Parasitology, Sakai City, Japan, October 7-8, 1995

Onishi, M.; Ueda, T.; Omachi, K.; Honda, T.; Nomura, M.; Nagata, R.; Hamasu, Y.; Sumi, N., 1994:
52-week oral toxicity study of lactitol (NS-4) in dogs followed by 9-week recovery test

Okazaki, S.; Kobayashi, J.; Tamura, K.; Nagatani, M.; Hamasu, Y.; Sumi, N., 1994:
52-week oral toxicity study of lactitol (NS-4) in rats followed by 9-week recovery test

Chan, E.K.; D.D.nato, F.; Hamel, J.C.; Tseng, C.E.; Buyon, J.P., 1995:
52-kD SS-A/Ro: genomic structure and identification of an alternatively spliced transcript encoding a novel leucine zipper-minus autoantigen expressed in fetal and adult heart

American Academy, O.Oral And Maxillofacial Pathology, 1998:
52nd Annual Meeting and Continuous Education of the American Academy of Oral and Maxillofacial Pathology

American-Academy-For-Cerebral-Palsy-And-Developmental-Medicine, 1998:
52nd Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine (San Antonio, Texas, USA; September 16-19, 1998)

American Academy, O.Oral Medicine, 1998:
52nd Annual Meeting of the American Academy of Oral Medicine

Canadian-Society-Of-Otorhinolaryngology-Head-And-Neck-Surgery, 1998:
52nd Annual Meeting of the Canadian Society of Otolaryngology-Head and Neck Surgery (Montreal, Quebec, Canada; June 14-17, 1998)

German Society For Digestive And Metabolic Diseases, 1997:
52nd Annual Meeting of the German Society for Digestive and Metabolic Diseases, Ludwigshafen, Germany, September 17-20, 1997

German-Society-For-Obstetrics-And-Gynecology, 1998:
52nd Congress of the German Society for Obstetrics and Gynecology (Nuernberg, Germany; September 8-12, 1998)

Voskanyan, K.S.; Arzumanyan, G.M., 1996:
532 nm laser light radioprotective action

German-Society-For-Digestive-And-Metabolic-Diseases-And-Section-For-Gastroenterological-Endoscopy, 1998:
53rd Annual Meeting of the German Society for Digestive and Metabolic Diseases with the Section for Gastroenterological Endoscopy (Kiel, Germany; September 2-5, 1998)

Society-Of-Biological-Psychiatry, 1998:
53rd Annual Scientific Convention and Scientific Program of the Society of Biological Psychiatry (Toronto, Ontario, Canada; May 27-31, 1998)

Moser, D.-Martin; Palese, R., 1996:
54th Swiss Floristic Notes (1995-1996)

Herbein, G.; Gordon, S., 1997:
55- and 75-kilodalton tumor necrosis factor receptors mediate distinct actions in regard to human immunodeficiency virus type 1 replication in primary human macrophages

Tayebi, N.; Stern, H.; Dymarskaia, I.; Herman, J.; Sidransky, E., 1996:
55-base pair deletion in certain patients with Gaucher disease complicates screening for common Gaucher alleles

Japanese Society, O.Parasitology, 1995:
55th East Japan Regional Meeting of the Japanese Society of Parasitology, Tokyo, Japan, October 14, 1995

Moser, D.-Martin; Palese, R., 1997:
55th Swiss floristic notes (1996-1997)

German Chemical Society Food Chemistry Group, 1997:
55th Workshop of the Southwest Regional Association of the Food Chemistry Group of the German Chemical Society, Trier, Germany, February 24-25, 1997

American Diabetes Association (Usa), 1996:
56th Annual Meeting and Scientific Sessions of the American Diabetes Association, San Francisco, California, USA, June 8-June 11, 1996

Ertel, Wolfgang, 1997:
56th Annual Meeting of the American Association for the Surgery of Trauma (Houston, Texas, USA, September 19-21, 1996)

American Psychosomatic Society, 1998:
56th Annual Meeting of the American Psychosomatic Society, Clearwater Beach, Florida, USA, March 11-14, 1998

Japanese Society, O.Parasitology, 1996:
56th East Japan Regional Meeting of the Japanese Society of Parasitology, Matsumoto City, Japan, October 5, 1996

Food-Chemistry-Society-(Southwest-Regional-Association), 1998:
56th Meeting of the Southwest Regional Association of the Food Chemistry Society of the Society of German Chemists (Giessen, Germany; March 9-10, 1998)

Dutch Society, O.Nephrology, 1997:
56th Scientific Meeting of the Dutch Society of Nephrology, Groningen, Netherlands, October 12, 1996

American Diabetes Assocation, 1997:
57th Annual Meeting and Scientific sessions of the American Diabetes Association, Boston, Massachusetts, USA, June 21-24, 1997

Dutch Society, O.Nephrology, 1997:
57th Scientific Meeting of the Dutch Society of Nephrology, Nijmegen, Netherlands, February 17, 1997

Bashour, A.M.; Bloom, G.S., 1998:
58K, a microtubule-binding Golgi protein, is a formiminotransferase cyclodeaminase

American-Diabetes-Association, 1998:
58th Scientific Sessions of the American Diabetes Association (Chicago, Illinois, USA; June 13-16, 1998)

Galatius, S.; Launbjerg, J.; Mortensen, L.S.; Hansen, J.F., 1998:
5993 survivors of suspected myocardial infarction. 10 year incidence of later myocardial infarction and subsequent mortality

Moura, E.; Verheul, A.F.; Marx, J.J., 1998:
59Fe labelling of rabbit erythrocytes as a continuous source for iron metabolism studies

American Academy, O.Physical Medicine And Rehabilitation, 1997:
59th Annual Assembly of the American Academy of Physical Medicine and Rehabilitation, Atlanta, Georgia, USA, November 13-16, 1997

Fadool, J.M.; Linser, P.J., 1993:
5A11 antigen is a cell recognition molecule which is involved in neuronal-glial interactions in avian neural retina

Bertolotto, A.; Agresti, C.; Castello, A.; Manzardo, E.; Riccio, A., 1998:
5D4 keratan sulfate epitope identifies a subset of ramified microglia in normal central nervous system parenchyma

Hering, R.; Glover, V.; Pattichis, K.; Catarci, T.; Steiner, T.J., 1993:
5HT in migraine patients with medication-induced headache

Sillar, K.T.; Simmers, A.J., 1994:
5HT induces NMDA receptor-mediated intrinsic oscillations in embryonic amphibian spinal neurons

Urbina, M.; Schmeer, C.; Lima, L., 1996:
5HT-1A receptor agonist differentially increases cyclic AMP concentration in intact and lesioned goldfish retina. In vitro inhibition of outgrowth by forskolin

Pickard, G.E.; Weber, E.T.; Scott, P.A.; Riberdy, A.F.; Rea, M.A., 1996:
5HT1B receptor agonists inhibit light-induced phase shifts of behavioral circadian rhythms and expression of the immediate-early gene c-fos in the suprachiasmatic nucleus

Erzegovesi, S.; Ronchi, P.; Smeraldi, E., 1992:
5HT-2 receptor and fluvoxamine effect in obsessive-compulsive disorder

Chabriat, H.; Tehindrazanarivelo, A.; Vera, P.; Samson, Y.; Pappata, S.; Boullais, N.; Bousser, M.G., 1995:
5HT-2 receptors in cerebral cortex of migraineurs studied using PET and 18F-fluorosetoperone

Goudreau, J.L.; Manzanares, J.; Lookingland, K.J.; Moore, K.E., 1993:
5HT2 receptors mediate the effects of stress on the activity of periventricular hypophysial dopaminergic neurons and the secretion of alpha-melanocyte-stimulating hormone

Cerrito, F.; Lazzaro, M.P.; Gaudio, E.; Arminio, P.; Aloisi, G., 1993:
5HT2-receptors and serotonin release: their role in human platelet aggregation

Moreau, J.L.; Boes, M.; Jenck, F.; Martin, J.R.; Mortas, P.; Wichmann, J., 1996:
5HT-2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats

Coccaro, E.F.; Kavoussi, R.J.; Oakes, M.; Cooper, T.B.; Hauger, R., 1996:
5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects

Sargent, P.A.; Sharpley, A.L.; Williams, C.; Goodall, E.M.; Cowen, P.J., 1997:
5HT-2c receptor activation decreases appetite and body weight in obese subjects

Arnold, B.; Allison, K.; Ivanova, S.; Paetsch, P.R.; Paslawski, T.; Greenshaw, A.J., 1995:
5HT-3 receptor antagonists do not block nicotine induced hyperactivity in rats

Park, S.B.G.; Smith, A.P.; Cowen, P.J., 1993:
5HT-3 receptor blockade in nicotine withdrawal: Study with BRL 46470A

Cardenas, C.G.; Del Mar, L.P.; Cooper, B.Y.; Scroggs, R.S., 1997:
5HT4 receptors couple positively to tetrodotoxin-insensitive sodium channels in a subpopulation of capsaicin-sensitive rat sensory neurons

Li, D.L.; Simmons, R.M.A.; Iyengar, S., 1998:
5HT1A receptor antagonists enhance the functional activity of fluoxetine in a mouse model of feeding

Wu, C.F.; Liu, J.; Consolo, S.; Liu, W., 1998:
5HT1A receptors mediate inhibition of ethanol-induced ascorbic acid release in rat striatum studied by microdialysis

Bonaventure, P.; Voorn, P.; Luyten, W.H.; Leysen, J.E., 1998:
5HT1B and 5HT1D receptor mRNA differential co-localization with peptide mRNA in the guinea pig trigeminal ganglion

Cavallini, M.C.istina; D.B.lla, D.; Pasquale, L.; Henin, M.; Bellodi, L., 1998:
5HT2C CYS23/SER23 polymorphism is not associated with obsessive-compulsive disorders

Gongadze, G.; Kashparov, I.; Lorenz, S.; Schroeder, W.; Erdmann, V.A.; Liljas, A.; Garber, M., 1996:
5S rRNA binding ribosomal proteins from Thermus thermophilus: Identification and some structural properties

Szymanski, M.; Specht, T.; Barciszewska, M.Z.; Barciszewski, J.; Erdmann, V.A., 1998:
5S rRNA Data Bank

Bruenger, E.; Kowalak, J.A.; Kuchino, Y.; McCloskey, J.A.; Mizushima, H.; Stetter, K.O.; Crain, P.F., 1993:
5S rRNA modification in the hyperthermophilic archaea Sulfolobus solfataricus and Pyrodictium occultum

Délos, S.; Carsol, J.L.; Fina, F.; Raynaud, J.P.; Martin, P.M., 1998:
5alpha-reductase and 17beta-hydroxysteroid dehydrogenase expression in epithelial cells from hyperplastic and malignant human prostate

Uyttebroeck, A.; Brock, P.; D.G.oote, B.; Renard, M.; Dal Cin, P.; Van Den Berghe, H.; Casteels Van Daele, M., 1995:
5q - Syndrome in a child

Jonveaux, P.; Daniel, M.T.erese; Berger, R., 1993:
5q- Anomaly preceding acute myeloblastic leukemia with 53 chromosomes with chromosome 5 abnormality

Soligo, D.; Romitti, L.; Bertolli, V.; Della Volpe, A.; Annaloro, C.; Lambertenghi Deliliers, G., 1995:
5q- in a case of chronic myelogenous leukemia relapsed after allogeneic bone marrow transplantation

Van-Den-Berghe, H.; Michaux, L., 1997:
5q-, twenty-five years later: A synopsis

Pedersen, B., 1993:
5q-: pathogenetic importance of the common deleted region and clinical consequences of the entire deleted segment

Pedersen, Bent, 1997:
5q-:P Does longer survival of female patients explain the preponderance?

Berger, R.; L.C.niat, M.; Derre, J., 1992:
5q-minus anomaly in acute lymphoblastic leukemia

Shpanchenko, O.V.; Zvereva, M.I.; Dontsova, O.A.; Nierhaus, K.H.; Bogdanov, A.A., 1996:
5s rRNA sugar-phosphate backbone protection in complexes with specific ribosomal proteins

Photomedicine Society (Usa), 1996:
5th Annual Meeting of the Photomedicine Society, Washington, DC, USA, February 9, 1996

International Academy, O.Pathology (Hong Kong Division)., 1997:
5th Annual Scientific Meeting of the Hong Kong Division of the International Academy of Pathology, Hong Kong, Hong Kong, November 16-17, 1996

Kraugh-Siegel, R.L.; Schoeneck, R., 1996:
5th Conference of the European Cooperation in the Field of Scientific and Technical Research (COST) Action 815 on Antiparasitic Chemotherapy at the Internationales Wissenschaftsforum, Heidelberg, Germany, May 23-14, 1996

Asia-Pacific-Association-Of-Societies-Of-Pathologists, 1997:
5th Congress of Asia Pacific Association of Societies of Pathologists and the 9th National Congress of Pathology (Bangkok, Thailand; December 2-5, 1997)

European Society, O.Magnetic Resonance, I.Neuropediatrics, 1997:
5th Congress of the European Society of Magnetic Resonance in Neuropediatrics, Amsterdam, The Netherlands, December 18-20, 1997

International-Society-For-Rotary-Blood-Pumps, 1998:
5th Congress of the International Society for Rotary Blood Pumps (Marseille, France; September 10-12, 1997)

Jacopini, G., 1997:
5th European Meeting on Psychological Aspects of Genetics, Rome, Italy, September 26-28, 1996

International-Society-For-Trace-Elements-Research-In-Humans, 1998:
5th International Conference of the International Society for Trace Elements Research in Humans (New Aspects of Trace Element Research) (Lyon, France; September 26-30, 1998)

Hughes, Graham, R.V., 1998:
5th International Conference on Systemic Lupus Erythematosus (Cancun, Mexico; April 20-25, 1998)

Niemitz, Carsten, 1998:
5th International Congress of the German Primate Society (Berlin, Germany; October 1-5, 1997)

Anonymous, 1998:
5th International Congress on Research and Therapeutics in Osteoarthritis (Interleuken-1 inhibitors) (Mandelieu-la-Napoule, France; January 31-February 1, 1998)

Kork, J.; Den-Boer, J.A.; Oosterveld, E.; De-Wolf, A., 1998:
5th International Symposium of the International Society for Neuroimaging in Psychiatry (Groningen, Netherlands; November 27-29, 1997)

Anonymous, 1998:
5th International Symposium on Dendritic Cells in Fundamental and Clinical Immunology (Pittsburgh, Pennsylvania, USA; September 23-28, 1998)

European-Society-For-Pediatric-Gastroenterology-And-Nutrition-And-North-American-Society-For-Pediatric-Gastroenterology, 1998:
5th Joint Meeting of the European Society for Pediatric Gastroenterology and Nutrition and the North American Society for Pediatric Gastroenterology (Toulouse, France; May 27-30, 1998)

Anonymous, 1997:
5th KBF Symposium: From Genes to Behavior: A Basis for the Study of Psychopathology, Mannheim, Germany

Anonymous, 1998:
5th Meeting of Therapeutics (Toulon, France; February 5, 1998)

European Society, O.Mastology, 1997:
5th Nottingham International Breast Cancer Conference, Nottingham, England, UK, September 17-19, 1997

Society For Biochemistry And Molecular Biology (Germany)., 1997:
5th Photosynthesis Workshop Northwest held at the 139th Conference of the Society for Biochemistry and Molecular Biology, Duesseldorf, Germany, November 25, 1996

Schantz, S.P.; Steinberg, B.M., 1998:
5th Research Workshop on the Biology, Prevention, and Treatment of Head and Neck Cancer

French-Society-Of-Human-Genetics, 1997:
5th Scientific Meeting of the French Society of Human Genetics (Paris, France; December 2-3, 1997)

British Society, O.Gastroenterology, 1996:
5th United European Gastroenterology Week, Paris, France, November 2-6, 1996

Taeger, Andreas, 1992:
5th contribution to the knowledge of the sawfly genus Tenthredo L. (Hymenoptera, Symphyta)

Zhai, G.; Yuan, X., 1997:
6 cases of primary intraventricular hemorrhage

Voirin, J.P., 1996:
6 new species of Dynastinae (Col. Scarabaeoidea)

Palma, H.; Paredes, J., C.; Cristi, E., 1991:
6' 6'-Dibromoindigotin in embryo capsules of Concholepas concholepas (Burguiere 1789)

Altmann, K.-Heinz; Kesselring, R.; Pieles, U., 1996:
6'-Carbon-substituted carbocyclic analogs of 2'-deoxyribonucleosides - synthesis and effect on DNA/RNA duplex stability

Han, J.-Kwon; Chung, S.-Oh; Lee, J.-Heung; Byun, S.-Myung, 1997:
6'-Mercaptoguanosine-resistance is related with purF gene encoding 5'-phosphoribosyl-1'-pyrophosphate amidotransferase in inosine-5'-monophosphate overproducing Brevibacterium ammoniagenes

Takeda, Y.; Tamura, K.; Matsumoto, T.; Terao, H.; Tabata, M.; Fujita, T.; Honda, G.; Sezik, E.; Yesilada, E., 1993:
6'-O-Benzoylshanzhiside methyl ester from Rhinanthus angustifolius ssp. grandiflorus

Hemmerich, S.; Rosen, S., D., 1994:
6'-sulfated sialyl Lewis x is a major capping group of GlyCAM-1

Tsuboi, S.; Isogai, Y.; Hada, N.; King, J.K.; Hindsgaul, O.; Fukuda, M., 1996:
6'-Sulfo sialyl Lex but not 6-sulfo sialyl Lex expressed on the cell surface supports L-selectin-mediated adhesion

Bianco, A.; Guiso, M.; Mazzei, R.A.; Piccioni, F.; Nicoleti, M.; Serafini, M.; Ballero, M., 1996:
6'O-Acetylantirrhinoside, a new iridoid glucoside from Linaria flava subsp. sardoa

Seabra, R., M.; Moreira, M.M.nuela; Cruz-Costa, M.A.; Paul, M.I.abel, 1995:
6,3',4'-Trihydroxy-4-methoxy-5-methylaurone from Cyperus capitatus

Marder, M.; Viola, H.; Wasowski, C.; Wolfman, C.; Waterman, P., G.; Medina, J., H.; Paladini, A., C., 1995:
6,3'-Dinitroflavone, a novel high affinity ligand for the benzodiazepine receptor with potent anxiolytic properties

Rousset, S.; Nocentini, S.; Santella, R.M.; Moustacchi, E., 1997:
6,4,4'-Trimethylangelicin photoadduct immunodetection in DNA: induction and repair in Fanconi's anemia and normal human fibroblasts

Soyka, R.; Heckel, A.; Nickl, J.; Eisert, W.; Mueller, T.H.; Weisenberger, H., 1994:
6,6-Disubstituted Hex-5-enoic acid derivatives as combined thromboxane A2 receptor antagonists and synthetase inhibitors

Guzikowski, A., P.; Hawkinson, J.; Weber, E.; Keana, J., F.W., 1995:
6,7,8,9-Tetrahydro-3-hydroxy-1H-1-benzazepine-2,5-diones via a Diels-Alder reaction:antagonists with a non-planar hydrophobic region for NMDA receptor glycine sites

Stjernlof, P.; Elebring, T.; Nilsson, J.; Andersson, B.; Lagerkvist, S.; Svensson, K.; Ekman, A.; Carlsson, A.; Wikstrom, H., 1994:
6,7,8,9-tetrahydro-N,N-di-n-propyl-3H-benzindol-8-amines: Derivatives as potent and orally active serotonin 5-HT-1A receptor agonists

Villani, L.; Carraro, S.; Guarnieri, T., 1995:
6,7-Dinitroquinoxaline-2,3-dione but not MK-801 exerts a protective effect against kainic acid neurotoxicity in the goldfish retina

Jackson, H.C.; Biggadike, K.; McKilligin, E.; Kinsman, O.S.; Queener, S.F.; Lane, A.; Smith, J.E., 1996:
6,7-disubstituted 2,4-diaminopteridines: novel inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase

Silveira, E.R.; Mcchesney, J.D., 1994:
6,7-oxygenated neo-clerodane furan diterpenes from Croton sonderianus

Shen, X.; Isogai, A.; Furihata, K.; Lin, Z.; Sun, H.; Suzuki, A., 1994:
6,7-seco-ENT-kaurane diterpenoid from Rabdosia eriocalyx

Dolle, F.; Demphel, S.; Hinnen, F.; Fournier, D.; Vaufrey, F.; Crouzel, C., 1998:
6-(18F)Fluoro-L-DOPA by radiofluorodestannylation: A short and simple synthesis of a new labelling precursor

Ohmori, J.; Sakamoto, S.; Kubota, H.; Shimizu-Sasamata, M.; Okada, M.; Kawasaki, S.; Hidaka, K.; Togami, J.; Furuya, T.; Murase, K., 1994:
6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione hydrochloride (YM90K) and related compounds: Structure-activity relationships for the AMPA-type non-NMDA receptor

Kelley, J.L.; Bullock, R.M.; Krochmal, M.P.; McLean, E.W.; Linn, J.A.; Durcan, M.J.; Cooper, B.R., 1997:
6-(alkylamino)-9-alkylpurines. A new class of potential antipsychotic agents

Vicentini, C., B.; Guarneri, M.; Scatturin, A.; Giori, P.; Heilman, W., 1996:
6-Alkyl and 6-arylcarbamoyloximino pyrazolo(3,4-b)(1,4)diazepines as potential fungicidal, insecticidal and herbicidal agents

Numazawa, M.; Oshibe, M.; Yamaguchi, S., 1997:
6-Alkylandrosta-4,6-diene-3,17-diones and their 1,4,6-triene analogs as aromatase inhibitors: Structure-activity relationships

Grdisa, M.; Kralj, M.; Eckert Maksic, M.; Maksic, Z.B.; Pavelic, K., 1995:
6-Amino-6-deoxyascorbic acid induces apoptosis in human tumor cells

Ishida, J.; Yakabe, T.; Nohta, H.; Yamaguchi, M., 1997:
6-Aminomethylphthalhydrazide as a highly sensitive chemiluminescence derivatization reagent for 5-hydroxyindoles in liquid chromatography

Cecchetti, V.; Clementi, S.; Cruciani, G.; Fravolini, A.; Pagella, P.-Giuseppe; Savino, A.; Tabarrini, O., 1995:
6-Aminoquinolones: A new class of quinolone antibacterials?

Lecchi, P.; Le, H.M.; Pannell, L.K., 1995:
6-Aza-2-thiothymine: a matrix for MALDI spectra of oligonucleotides

Frye, S., V.; Haffner, C., D.; Maloney, P., R.; Mook, R., A.-Jr;, J., G., F.D.rsey; Hiner, R., N.; Cribbs, C., M.; Wheeler, T., N.; Ray, J., A.; Andrews, R., C.; Batchelor, K., W.; Bramson, H.N.al; Stuart, J.D.rren, 1994 :
6-Azasteroids: Structure-activity relationships for inhibition of type 1 and 2 human 5-alpha-reductase and human adrenal 3-beta-hydroxyl-DELTA-5-steroid dehydrogenase/3-keto-DELTA-5-steroid isomerase

Pass, B.; Furkart, A.J.; Dove, S.B.; Mcdavid, W.D.; Gregson, P.H., 1994:
6-Bit and 8-bit digital radiography for detecting simulated periodontal lesions

Marder, M.; Viola, H.; Wasowski, C.; Wolfman, C.; Waterman, P.G.; Cassel, B.K.; Medina, J.H.; Paladini, A.C., 1996:
6-Bromoflavone, a high affinity ligand for the central benzodiazepine receptors is a member of a family of active flavonoids

Campbell, J.J.; Bowman, E.P.; Murphy, K.; Youngman, K.R.; Siani, M.A.; Thompson, D.A.; Wu, L.; Zlotnik, A.; Butcher, E.C., 1998:
6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7

Saito, K.; Markey, S.P.; Heyes, M.P., 1994:
6-Chloro-D,L-tryptophan, 4-chloro-3-hydroxyanthranilate and dexamethasone attenuate quinolinic acid accumulation in brain and blood following systemic immune activation

Spengler, B.; Schmidt, J.; Voigt, B.; Adam, G., 1995:
6-Deoxo-28-norcastasterone and 6-deoxo-24-epicastasterone-two new brassinosteroids from Ornithopus sativus

Griffiths, P.G.; Sasse, J.M.; Yokota, T.; Cameron, D.W., 1995:
6-Deoxotyphasterol and 3-dehydro-6-deoxoteasterone, possible precursors to Brassinosteroids in the pollen of Cupressus arizonica

Riley, A., M.; Murphy, C., T.; Lindley, C., J.; Westwick, J.; Potter, B., V.L., 1996:
6-Deoxy-6-hydroxymethyl scyllo-inositol 1,2,4-trisphosphate: A potent agonist at the inositol 1,4,5-trisphosphate receptor

Defoin, A.; Sarazin, H.; Streith, J., 1997:
6-Deoxy-allo-nojirimycin in the racemic and D-series, 6-deoxy-D,L-talo-nojirimycin, their 1-deoxyderivatives and 6-deoxy-2-D,L-allosamine via Hetero-Diels-Alder cycloadditions

Defoin, A.; Sarazin, H.; Streith, J., 1997:
6-Deoxy-nojirimycin and 6-deoxy-gulo-Nojirimycin in the racemic and D-series, D-fuco-nojirimycin and their 1-deoxyderivatives via hetero-Diels-Alder cycloadditions

Vince, R.; Brownell, J.; Beers, S., A., 1995:
6-Deoxycarbovir: A xanthine oxidase activated prodrug of carbovir

Tsukamoto, N.; Chuck, J.A.; Luo, G.; Kao, C.M.; Khosla, C.; Cane, D.E., 1996:
6-deoxyerythronolide B synthase 1 is specifically acylated by a diketide intermediate at the beta-ketoacyl-acyl carrier protein synthase domain of module 2

Soike, K.F.; Huang, J.L.; Lambe, C.U.; Nelson, D.J.; Ellis, M.N.; Krenitsky, T.A.; Koszalka, G.W., 1993:
6-Dimethylamino-9-(beta-D-arabinofuranosyl)-9H-purine: pharmacokinetics and antiviral activity in simian varicella virus-infected monkeys

Chanut, E.; Bonnet, J.J.; Trouvin, J.H.; Plat, M.; Costentin, J.; Jacquot, C., 1994:
6-Fluoro-serotonin as a substrate for the neuronal serotonin transporter

Mehta, V., D.; Sivasubramanian, A.; Kulkarni, P., V.; Mason, R., P.; Antich, P., P., 1996:
6-Fluoropyridoxal polymer conjugates: Novel 19F pH indicators for magnetic resonance spectroscopy

Mehta, V., D.; Kulkarni, P., V.; Mason, R., P.; Constantinescu, A.; Aravind, S.; Goomer, N.; Antich, P., P., 1994:
6-Fluoropyridoxol: A novel probe of cellular pH using 19F NMR spectroscopy

Vazquez, J.L.; Montero, M.T.; Trias, J.; Hernandez-Borrell, J., 1998:
6-Fluoroquinolone-liposome interactions: Fluorescence quenching study using iodide

McGroarty, A.; Greenfield, S.A., 1997:
6-Hydroxy dopamine lesions block a tolbutamide-sensitive K+ conductance in the guinea-pig substantia nigra

Wikström, H.; Andersson, B.; Elebring, T.; Lagerkvist, S.; Hallnemo, G.; Pettersson, I.; Jovall, P.A.; Svensson, K.; Ekman, A.; Carlsson, A., 1992:
6-Hydroxy-3-n-propyl-2,3,4,5-tetrahydro-1H-3-benzazepine and analogs: new centrally acting 5-HT1A receptor agonists

Robson, K.J.; Stewart, M.E.len; Michelsen, S.; Lazo, N.D.; Downing, D.T., 1994:
6-Hydroxy-4-kspingenine in human epidermal ceramides

Tanganelli, S.; Ferraro, L.; Bianchi, C.; Fuxe, K., 1994:
6-Hydroxy-dopamine treatment counteracts the reduction of cortical GABA release produced by the vigilance promoting drug modafinil in the awake freely moving guinea-pig

Rueckert, N.; Bubser, M.; Schmidt, W.J., 1997:
6-Hydroxydopamine lesion of locus coeruleus and the antiparkinsonian potential of NMDA-receptor antagonists in rats

Jeon, B., S.; Jackson-Lewis, V.; Burke, R., E., 1995:
6-Hydroxydopamine lesion of the rat substantia nigra: Time Course and morphology of cell death

Gong, W.; Neill, D.; Justice, J.B.Jr, 1997:
6-Hydroxydopamine lesion of ventral pallidum blocks acquisition of place preference conditioning to cocaine

Venero, J.L.; Beck, K.D.; Hefti, F., 1994:
6-Hydroxydopamine lesion reduce BDNF mRNA levels in adult rat brain substantia nigra

Cole, D.G.; Kobierski, L.A.; Konradi, C.; Hyman, S.E., 1994:
6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons

Bubser, M., 1994:
6-Hydroxydopamine lesions of the medial prefrontal cortex of rats do not affect dopamine metabolism in the basal ganglia at short and long postsurgical intervals

Roberts, A.C.; D.S.lvia, M.A.; Wilkinson, L.S.; Collins, P.; Muir, J.L.; Everitt, B.J.; Robbins, T.W., 1994:
6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: possible interactions with subcortical dopamine

Simmons, K., E.; Jones, D., J., 1993:
6-Hydroxydopamine treatment of neonatal rats: I. Effects on the development of the spinal cord noradrenergic system

Simmons, K., E.; Jones, D., J., 1993:
6-Hydroxydopamine treatment of neonatal rats: II. Effects on the development of the hindlimb flexor reflex

Gervais, M.; Tan, L., 1993:
6-Hydroxyiminoandrostenedione, a new specific inhibitor of estrogen biosynthesis and its effect on T47D human breast cancer cells

Kobayashi, J.'ichi; Tsuda, M.; Kawasaki, N.; Sasaki, T.; Mikami, Y., 1994:
6-Hydroxymanzamine A and 3,4-dihydromanzamine A, new alkaloids from the Okinawan marine sponge Amphimedon sp

Martelli, A.M.; Neri, L.M.; Zamai, L.; Bareggi, R.; Manzoli, L.; Cocco, L., 1994:
6-Iodoacetamidofluorescein labelling to assess the state of sulphydryl groups after thermal stabilization of isolated nuclei

Woodward, D., F.; Pepperl, D., J.; Burkey, T., H.; Regan, J., W., 1995:
6-Isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809), a human EP-2 receptor antagonist

Levin, J.I.; Chan, P.S.; Coupet, J.; Bailey, T.K.; Vice, G.; Thibault, L.; Lai, F.; Venkatesan, A.M.; Cobuzzi, A., 1994:
6-Isoxazolinyl and isoxazolidinyl substituted quinazolinones as angiotensin II receptor antagonists

Starkov, A.A.; Dedukhova, V.I.; Skulachev, V.P., 1994:
6-Ketocholestanol abolishes the effect of the most potent uncouplers of oxidative phosphorylation in mitochondria

Kim, Y.H.; Song, T.B.k; Byun, J.S.o, 1996:
6-Ketoprostaglandin F-1alpha, thromboxane B-2, and endothelin-1 concentrations of maternal blood in preeclampsia

Dibenedetto, S.P.; Guardabasso, V.; Ragusa, R.; D.C.taldo, A.; Miraglia, V.; D'Amico, S.; Ippolito, A.M., 1994:
6-Mercaptopurine cumulative dose: a critical factor of maintenance therapy in average risk childhood acute lymphoblastic leukemia

Hortelano, S.; Boscá, L., 1997:
6-Mercaptopurine decreases the Bcl-2/Bax ratio and induces apoptosis in activated splenic B lymphocytes

Welch, J.C.; Lilleyman, J.S., 1996:
6-Mercaptopurine dose escalation and its effect on drug tolerance in childhood lymphoblastic leukaemia

Cuffari, C.; Theoret, Y.; Latour, S.; Seidman, G., 1996:
6-Mercaptopurine metabolism in Crohn's disease: Correlation with efficacy and toxicity

Bokkerink, J., P.M.; Stet, E., H.; De-Abreu, R., A.; Damen, F., J.M.; Hulscher, T., W.; Bakker, M., A.H.; Van-Baal, J., A., 1993:
6-Mercaptopurine: Cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts

Yoshino, N.; Kawaguchi, T.; Tokuoka, K.; Ishitani, T.; Hirata, T., 1993:
6-Methoxymellein levels in fresh carrots in relation to the sensory quality

Remennikov, G.Y.; Shavaran, S.S.; Boldyrev, I.V.; Kapran, N.A.; Kurilenko, L.K.; Shevchuk, V.G.; Klebanov, B.M., 1994:
6-Methyl- and 1,6-dimethyl-4-aryl-5-nitro-2-oxo-1,2,3,4-tetrahydropyrimidines as calcium entry modulators

Zacharewski, T.; Harris, M.; Biegel, L.; Morrison, V.; Merchant, M.; Safe, S., 1992 :
6-Methyl-1,3,8-trichlorodibenzofuran (MCDF) as an antiestrogen in human and rodent cancer cell lines: evidence for the role of the Ah receptor

Hanna, N., B.; Zajicek, J.; Piskala, A., 1997:
6-Methyl-5-azacytidine - synthesis, conformational properties and biological activity. A comparison of molecular conformation with 5-azacytidine

Roberson, K.M.; Padilla, G.M.; Schmidt, J.M.; Petrow, V.; Robertson, C.N., 1995:
6-Methylene progesterone is cytotoxic to human cancer cell lines independent of its 5-alpha-reductase activity

Ai, J.; Dekermendjian, K.; Wang, X.; Nielsen, M.; Witt, M.R.bin, 1997:
6-Methylflavone, a benzodiazepine receptor ligand with antagonistic properties on rat brain and human recombinant GABAA receptors in vitro

Picco, P.; Gattorno, M.; Buoncompagni, A.; Pistoia, V.; Borrone, C., 1996:
6-methylprednisolone 'mini-pulses': a new modality of glucocorticoid treatment in systemic onset juvenile chronic arthritis

Cromby, C.H.; Manning, N.J.; Pollitt, R.J.; Powell, S.; Bennett, M.J., 1994:
6-Methyluracil excretion in 2-methylacetoacetyl-CoA thiolase deficiency and in two children with an unexplained recurrent ketoacidaemia

Rasolonjatovo, I.; Sarfati, S., R., 1998:
6-N-(N-methylanthranylamido)-4-oxo-hexaonic acid: A new fluorescent protecting group applicable to a new DNA sequencing method

Pimpinelli, S.; Marini, A.; Babudri, N.; Morpurgo, G., 1997:
6-N-hydroxylaminopurine (HAP)-induced accumulation of variability in haploid and diploid strains of Aspergillus nidulans

Hashmi, S.A.N.deem; Adiraj, M.; Kumar, A.; Katti, S.B., 1994:
6-Nitrobenzotriazol-1-yloxytris(dimethylamino) phosphonium hexafluorophosphate (NBOP): A new coupling reagent in oligonucleotide synthesis

Gao, H.; Fathi, R.; Gaffney, B., L.; Goswami, B.; Kung, P.-Pei; Rhee, Y.; Jin, R.; Jones, R., A., 1992:
6-O-(Pentafluorophenyl)-2'-deoxyguanosine: A versatile synthon for nucleoside and oligonucleotide synthesis

Chassagne, D.; Crouzet, J.; Bayonove, C.L.; Brillouet, J.M.; Baumes, R.L., 1996:
6-O-alpha-L-Arabinopyranosyl-beta-D-glucopyranosides as aroma precursors from passion fruit

Chen, C.C.ih; Shen, C.C.ang; Shih, Y.Z.n; Pan, T.M.ng, 1994:
6-O-benzoylgomisin O, a new lignan from the fruits of Schizandra chinensis

Achenbach, H.; Fischer, A., 1997:
6-O-beta-D-glucoside of aristolochic acid IIIa and other compounds from the roots of Aristolochia baetica

Tahara, S.; Saitoh, F.; Mizutani, J., 1993:
6-O-methylluteone metabolism in Botrytis cinerea: Identification of the epoxy-intermediate and absolute configuration of the pyranoisoflavone metabolite

Winnicka, M.M., 1998:
6-OHDA bilateral lesions to the amygdala abolish the memory enhancing effect of angiotensin II in rats

Winnicka, M.M., 1996:
6-OHDA bilateral lesions to the central amygdala do not affect vasopressin improvement of recall in rats

Winnicka, M.M.lgorzata; Wisniewski, K., 1998:
6-OHDA bilateral lesions to the nucleus septi lateralis attenuate vasopressin improvement of recall in rats

Grigoryan, G.; Hodges, H.; Mitchell, S.; Sinden, J.D.; Gray, J.A., 1996:
6-OHDA lesions of the nucleus accumbens accentuate memory deficits in animals with lesions to the forebrain cholinergic projection system: effects of nicotine administration on learning and memory in the water maze

Winnicka, M.M.; Brasdzko, J.J.; Wisniewski, K., 1998:
6-OHDA lesions to amygdala and hippocampus attenuate memory-enhancing effect of the 3-7 fragment of angiotensin II

Winnicka, M.M.; Braszko, J.J., 1997:
6-OHDA lesions to the central amygdala abolish angiotensins facilitation of object recognition in rats

Sato, K.; Ueda, H.; Okumura, F.; Misu, Y., 1994:
6-OHDA-induced lesion of the nigrostriatal dopaminergic neurons potentiates the inhibitory effect of 7-OHDPAT, a selective D-3 agonist, on acetylcholine release during striatal microdialysis in conscious rats

Ikemoto, S.; Mcbride, W.J.; Murphy, J.M.; Lumeng, L.; Li, T.K.i, 1997:
6-OHDA-lesions of the nucleus accumbens disrupt the acquisition but not the maintenance of ethanol consumption in the alcohol-preferring P line of rats

Sidhu, K.S.; Stellar, J.R.; Garity, D.; Bruno, J.P., 1993:
6-OHDA-treated weanling rats show normal neuroleptic sensitivity as adults on LHSS

Berressem, R.; Engels, J.W., 1995:
6-Oxocytidine a novel protonated C-base analogue for stable triple helix formation

Jiang, J.L.; van Rhee, A.M.; Melman, N.; Ji, X.D.; Jacobson, K.A., 1996:
6-phenyl-1,4-dihydropyridine derivatives as potent and selective A3 adenosine receptor antagonists

Hamilton, H., W.; Tait, B., D.; Gajda, C.; Hagen, S., E.; Ferguson, D.; Lunney, E., A.; Pavlovsky, A.; Tummino, P., J., 1996:
6-Phenyl-6-alkylamido-5,6-dihydro-2H-pyran-2-ones: Novel HIV protease inhibitors

Numazawa, M.; Yamaguchi, S., 1998:
6-Phenylaliphatic-substituted androst-4-ene-3,17-diones as aromatase inhibitors: Structure-activity relationships

Bouma, C.L.; Reizer, J.; Reizer, A.; Robrish, S.A.; Thompson, J., 1997:
6-phospho-alpha-D-glucosidase from Fusobacterium mortiferum: cloning, expression, and assignment to family 4 of the glycosylhydrolases

Witt, E.; Frank, R.; Hengstenberg, W., 1993:
6-Phospho-beta-galactosidases of gram-positive and 6-phospho-beta-glucosidase B of gram-negative bacteria: comparison of structure and function by kinetic and immunological methods and mutagenesis of the lacG gene of Staphylococcus aureus

D.F.utos, P.G.rcia; Baanante, I.V., 1994:
6-Phosphofructo 2-kinase/fructose 2,6-bisphosphatase in liver of the teleost Sparus aurata

Schroeter, A.; Kopperschlaeger, G., 1996:
6-phosphofructo-1-kinase from the lipid accumulating, non-fermentative, red yeast Rhodotorula glutinis

Vazquez Illanes, M.D.lores; Storey, K.B., 1993:
6-Phosphofructo-2-kinase and control of cryoprotectant synthesis in freeze tolerant frogs

Pyko, M.; Rider, M.H.; Hue, L.; Wegener, G., 1993:
6-Phosphofructo-2-kinase-fructose-2,6-bisphosphatase from frog skeletal muscle: Purification, kinetics and immunological properties

Rodriguez, M.; Wedd, A.G.; Scopes, R.K., 1996:
6-phosphogluconate dehydratase from Zymomonas mobilis: an iron-sulfur-manganese enzyme

Nishino, T.; Morita, T., 1994:
6-Phosphogluconate dehydrogenase (6PGD) gene duplication in Kalimeris (Asteraceae)

Hanau, S.; Rippa, M.; Bertelli, M.; Dallocchio, F.; Barrett, M.P., 1996:
6-Phosphogluconate dehydrogenase from Trypanosoma brucei. Kinetic analysis and inhibition by trypanocidal drugs

Holden, C., P.; Storey, K., B., 1994:
6-Phosphogluconate dehydrogenase from a freeze tolerant insect: Control of the hexose monophosphate shunt and NADPH production during cryoprotectant synthesis

Uyama, T.; Kinoshita, T.; Takahashi, H.; Satoh, N.; Kanamori, K.; Michibata, H., 1998:
6-Phosphogluconate dehydrogenase is a 45-kDa antigen recognized by S4D5, a monoclonal antibody specific to vanadocytes in the vanadium-rich ascidian Ascidia sydneiensis samea

Bürgisser, D.M.; Thöny, B.; Redweik, U.; Hess, D.; Heizmann, C.W.; Huber, R.; Nar, H., 1995:
6-Pyruvoyl tetrahydropterin synthase, an enzyme with a novel type of active site involving both zinc binding and an intersubunit catalytic triad motif; site-directed mutagenesis of the proposed active center, characterization of the metal binding site and modelling of substrate binding

Liu, H.; Santostefano, M.; Lu, Y.; Safe, S., 1993:
6-substituted 3,4-benzocoumarins: a new structural class of inducers and inhibitors of CYP1A1-dependent activity

Felczak, K.; Drabikowska, A.K.; Vilpo, J.A.; Kulikowski, T.; Shugar, D., 1996:
6-Substituted and 5,6-disubstituted derivatives of uridine: stereoselective synthesis, interaction with uridine phosphorylase, and in vitro antitumor activity

Vince, R.; Kilama, J.; Pham, P., T.; Beers, S., A.; Bowdon, B., J.; Keith, K., A.; Parker, W., B., 1995:
6-Substituted derivatives of carbovir: Anti-HIV activity

Levin, J.I.; Venkatesan, A.M.; Chan, P.S.; Bailey, T.K.; Vice, G.; Coupet, J., 1994:
6-Substituted quinazolinone angiotensin II receptor antagonists

Katz, V.L.; Ekstrom, R.D.; Mason, G.A.; Golden, R.N., 1995:
6-sulfatoxymelatonin levels in pregnant women during workplace and nonworkplace stresses: a potential biologic marker of sympathetic activity

Ben Shlomo, R.; Nevo, E.; Ritte, U.; Steinlechner, S.; Klante, G., 1996:
6-Sulphatoxymelatonin secretion in different locomotor activity types of the blind mole rat Spalax ehrenbergi